Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.1490961503562187e-35,18.00850460666194,1437.5366400234604,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.237879382605182e-32,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.5422013558234922e-16,6.101616021978598,222.1485552777056,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'UCP1', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1E', 'UQCRQ']",4.441539904771658e-14,0,0,52
3,Oxidative phosphorylation WP623,1.0462215533982506e-08,5.250073325046439,96.47269923474934,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",2.008745382524641e-06,0,0,28
4,Nonalcoholic fatty liver disease WP4396,3.293674434423839e-08,2.750060024009604,47.37989575507153,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'PRKAG2', 'COX6A1', 'COX7C', 'CASP7', 'LEPR', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'IL1B', 'PPARA', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CCL2', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'VCAM1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'UQCRQ', 'LEP', 'CYCS', 'BAX']",4.742891185570328e-06,0,0,54
5,"GPCRs, Class A Rhodopsin-like WP455",2.15554026955368e-07,2.46704280155642,37.869240850077695,"['NPFFR2', 'GPR27', 'OXTR', 'CHRM1', 'GPR68', 'GPR65', 'GPR22', 'NPY2R', 'GPR20', 'ADRA1D', 'MC4R', 'CYSLTR2', 'ADORA3', 'GPR171', 'PTGDR', 'GPR35', 'OR2H2', 'SSTR1', 'SSTR3', 'TRHR', 'ADORA2A', 'OR7A5', 'APLNR', 'OR3A3', 'OR3A2', 'CX3CR1', 'GPR87', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'ADRB2', 'MCHR1', 'HRH1', 'OR2AG1', 'RHO', 'DRD2', 'DRD3', 'NTSR1', 'DRD5', 'GPR17', 'GPR12', 'HTR1E', 'P2RY14', 'GPR52', 'HTR1B', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'OR7C1', 'GPR18']",2.4831823905258393e-05,0,0,57
6,Mitochondrial CIV Assembly WP4922,4.782683294729299e-07,6.289484058542355,91.53145210682148,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",4.591375962940127e-05,0,0,19
7,Complement and Coagulation Cascades WP558,2.5459816598671246e-05,3.4132954369511843,36.10723574459836,"['C1QB', 'C1QA', 'CPB2', 'SERPINA1', 'CR1', 'VWF', 'CFH', 'SERPIND1', 'F12', 'SERPINF2', 'C5AR1', 'CFI', 'PLG', 'F2', 'TFPI', 'F5', 'THBD', 'F7', 'C6', 'C7', 'C9', 'MASP2', 'C1QC']",0.0020949791944049486,0,0,23
8,Apoptosis Modulation and Signaling WP1772,5.385936401386954e-05,2.5529704680557046,25.093489540292506,"['BCL2A1', 'CASP7', 'BCL2L10', 'CAPNS1', 'CASP6', 'CASP10', 'BAG3', 'CASP4', 'CASP1', 'TNFSF10', 'PMAIP1', 'BMF', 'FADD', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'IL1R1', 'BAD', 'IL1R2', 'TNFRSF10C', 'TNFRSF10B', 'TNFRSF10A', 'TNFRSF1B', 'PTPN13', 'TNFRSF10D', 'TOLLIP', 'CYCS', 'BAX', 'PRKD1', 'BCL2L2', 'HSPA1A']",0.0038778742089986065,0,0,32
9,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0001411551930879544,3.1144893899204242,27.611974767902794,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.009033932357629082,0,0,21
10,Spinal Cord Injury WP2431,0.0003136589154855482,2.153573728267869,17.373319497056876,"['C1QB', 'CDKN1B', 'XYLT1', 'CXCL1', 'RTN4', 'TNFSF13B', 'LGALS3', 'ACAN', 'ZFP36', 'CHST11', 'MYC', 'CCL2', 'SLIT3', 'ROS1', 'MAPK3', 'NGFR', 'EGR1', 'IL1R1', 'GADD45A', 'BDNF', 'MIF', 'PDYN', 'SELP', 'NR4A1', 'VCAN', 'FCGR2A', 'IL1B', 'LEP', 'APEX1', 'CDK2', 'CDK1', 'CSPG4', 'LTB', 'VIM', 'TLR4']",0.01686253254803692,0,0,35
11,Nuclear Receptors Meta-Pathway WP2882,0.0003220275312993162,1.65150310245261,13.2795275566915,"['SERPINA1', 'CDKN1B', 'SRXN1', 'SLC2A2', 'SLC7A11', 'THBD', 'ZIC2', 'MYC', 'FTH1', 'SLCO2B1', 'ENC1', 'PDK4', 'CYP1B1', 'SLC39A7', 'GGT2', 'SLC39A3', 'SRGN', 'ABCC3', 'HSP90AA1', 'SERPINB2', 'ABCC2', 'SLC2A10', 'GPX3', 'HGF', 'SLC2A12', 'MYOF', 'CYP4A11', 'SLC39A11', 'AIP', 'APOA1', 'SLC39A12', 'TGFBR2', 'TGFBR3', 'KAT2B', 'CYP2A6', 'CDC37', 'IL1B', 'ANGPTL4', 'PPARA', 'EPHA2', 'FKBP5', 'FTL', 'NR1I3', 'AMIGO2', 'SLC5A12', 'TXN', 'SLC5A2', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'FOXO1', 'CYP3A7', 'PRRG4', 'FGD4', 'HMOX1', 'CCL2', 'STOM', 'IP6K3', 'CBR3', 'EGR1', 'JUN', 'GADD45B', 'SLC10A1', 'CAVIN2', 'PLK2', 'SLC2A9', 'BHLHE40', 'CDK1', 'BAX', 'SPRY1', 'HSPA1A']",0.01686253254803692,0,0,73
12,Sleep regulation WP3591,0.0005003690512448043,3.7585545251039334,28.56563315905108,"['CHRNB2', 'OXTR', 'AHCY', 'NPY2R', 'HCRTR2', 'HCRTR1', 'STAR', 'ADORA2A', 'CRH', 'UTS2', 'GHRL', 'DRD2', 'DRD3', 'PTGDR']",0.024017714459750605,0,0,14
13,Glycolysis and Gluconeogenesis WP534,0.000714429724791412,3.043747332479727,22.0489845741179,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A2', 'ENO2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'PFKM', 'GAPDH']",0.03165473242152718,0,0,17
14,Thyroxine (Thyroid Hormone) Production WP1981,0.0012268356917636398,21.439732142857142,143.71732165109626,"['TPO', 'TG', 'TRH', 'CGA', 'TSHR']",0.050475525603989754,0,0,5
15,Selenium Micronutrient Network WP15,0.0013922246776644387,2.2397839109970046,14.730728019685618,"['SERPINA3', 'PLG', 'TXN', 'SELENOK', 'SELENOH', 'PRDX3', 'PRDX5', 'KYNU', 'RFK', 'PNPO', 'CCL2', 'SEPHS2', 'XDH', 'GGT2', 'ABCA1', 'GPX4', 'GPX3', 'DIO3', 'APOA1', 'F2', 'KMO', 'F7', 'SELENOM', 'IL1B', 'SELENOW']",0.05346142762231445,0,0,25
16,Proximal tubule transport WP4917,0.0016664857880883117,2.5514894298526585,16.321975319690452,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'SLC2A2', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0D2', 'ATP6V0C', 'ATP6V1D', 'ABCG2', 'ATP6V1B1', 'ATP6V1F']",0.054957100376142834,0,0,19
17,Imatinib and Chronic Myeloid Leukemia WP3640,0.0016722417969685132,4.291919514532099,27.440774372893188,"['PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'CDKN1B', 'FLT1', 'GADD45A', 'MYC', 'PIM2', 'ABCG2']",0.054957100376142834,0,0,10
18,Blood Clotting Cascade WP272,0.0017174093867544636,4.827586206896552,30.736943488581787,"['F7', 'F8A1', 'SERPINB2', 'VWF', 'F12', 'SERPINF2', 'PLG', 'F2', 'F5']",0.054957100376142834,0,0,9
19,Complement system WP2806,0.0026312682066420615,2.070293086023423,12.298139952000016,"['FKBP2', 'CFH', 'CFI', 'C5AR1', 'ICAM2', 'C4BPA', 'PLG', 'TXN', 'LRP2', 'FCGR3A', 'C6', 'RPS19', 'C7', 'C9', 'CD59', 'VSIG4', 'PRNP', 'CR1', 'CD93', 'F12', 'APOA1', 'SELE', 'SELP', 'MASP2', 'PTX3', 'TLR2']",0.07976897300135934,0,0,26
20,Computational Model of Aerobic Glycolysis WP4629,0.002800925601480568,6.0051691129546905,35.29721510657428,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.08066665732264036,0,0,7
21,Mitochondrial complex III assembly WP4921,0.0029457495911647384,4.903013998449683,28.57178437472481,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0807977030719471,0,0,8
22,Peptide GPCRs WP24,0.003379672101896027,2.4164265129683,13.749410279290021,"['CX3CR1', 'OXTR', 'NPY2R', 'C5AR1', 'TACR2', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'GNRHR', 'TAC4', 'NTSR1']",0.08848596048600507,0,0,18
23,"GPCRs, Other WP117",0.00383454731695175,2.1487656300096183,11.95509569661421,"['GPR17', 'ADGRV1', 'GPR88', 'GPR55', 'ADRA1D', 'GPR83', 'ADRB2', 'GPR84', 'ADGRE2', 'PROKR2', 'SMO', 'ADORA2A', 'ADORA3', 'HRH4', 'GNRHR', 'OR10A2', 'LGR6', 'OR3A3', 'DRD3', 'NTSR1', 'GPR18', 'GPR135']",0.09603040237235687,0,0,22
24,White fat cell differentiation WP4149,0.004349276095032878,3.0299475494895947,16.476084751329047,"['CEBPB', 'TCF7L1', 'EGR2', 'MECOM', 'DDIT3', 'EBF1', 'RORA', 'GATA2', 'ZNF423', 'KLF4', 'KLF15', 'FOXO1']",0.10438262628078908,0,0,12
25,Constitutive Androstane Receptor Pathway WP2875,0.00596355686953753,3.3007395032307203,16.90667881364551,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.13740035027414468,0,0,10
26,Differentiation of white and brown adipocyte WP2895,0.010032273235784182,3.217432950191571,14.8064593202274,"['PLAC8', 'CEBPB', 'LEP', 'ZIC1', 'PRDM16', 'EBF3', 'SLC7A10', 'ZNF423', 'BMP7']",0.21184612594504387,0,0,9
27,Hematopoietic Stem Cell Differentiation WP2849,0.010176507502781616,2.2159690322580645,10.166142186965336,"['CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'ABO', 'FLI1', 'RUNX1', 'LYL1', 'TPO', 'IL5', 'IL1B', 'CD34']",0.21184612594504387,0,0,16
28,Glucocorticoid Receptor Pathway WP2880,0.010298075566772966,1.997719872134006,9.141163073685933,"['SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'CAVIN2', 'NR1I3', 'PLK2', 'AMIGO2', 'TGFBR3', 'PRRG4', 'THBD', 'FGD4', 'ZIC2', 'ENC1', 'BHLHE40', 'CCL2', 'STOM', 'SPRY1', 'ANGPTL4']",0.21184612594504387,0,0,20
29,Pre-implantation embryo WP3527,0.01211379921029682,2.311234655974023,10.20042624835312,"['EGR1', 'DLX2', 'TCF7L1', 'FOXD1', 'HMGA1', 'ATP1A1', 'GATA2', 'KLF4', 'AQP3', 'TBX3', 'ZFP36', 'ARGFX', 'DDIT3', 'SIX3']",0.24060511534934373,0,0,14
30,Cori Cycle WP1946,0.013390978252925193,3.752393107849394,16.184724628745137,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'SLC2A2', 'ALDOA', 'GAPDH']",0.24881301528015842,0,0,7
31,Platelet-mediated interactions with vascular and circulating cells WP4462,0.013390978252925193,3.752393107849394,16.184724628745137,"['SELP', 'VCAM1', 'IL1B', 'CCL2', 'SELE', 'TLR4', 'TLR2']",0.24881301528015842,0,0,7
32,Cellular Proteostasis WP4918,0.013882464988468278,8.572521517373287,36.66577821487967,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.249884369792429,0,0,4
33,Lung fibrosis WP3624,0.015485013938290017,2.1461932181701857,8.945081296080902,"['EDN1', 'CEBPB', 'SERPINA1', 'HGF', 'MMP2', 'FAM13A', 'FGF2', 'BMP7', 'CYSLTR2', 'IL5', 'IL1B', 'CCL3', 'HMOX1', 'CCL2', 'PTX3']",0.270283879650153,0,0,15
34,Kynurenine Pathway and links to Cellular Senescence WP5044,0.01690317525451485,3.119171285146389,12.727010457312304,"['CDKN1A', 'IL1R2', 'HAAO', 'KYNU', 'KMO', 'TLR4', 'FOXO1', 'ACMSD']",0.2863596749000163,0,0,8
35,NRF2 pathway WP2884,0.018451367101027193,1.5991981269682167,6.38498533004938,"['SERPINA1', 'SRXN1', 'SLC2A2', 'SLC5A12', 'TXN', 'SLC7A11', 'SLC5A2', 'SLC5A3', 'SLC5A4', 'FTH1', 'HMOX1', 'SLC39A7', 'GGT2', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'ABCC2', 'GPX3', 'SLC2A10', 'HGF', 'CYP4A11', 'SLC2A12', 'SLC39A11', 'SLC39A12', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'FTL', 'EPHA2', 'HSPA1A']",0.30365678429119036,0,0,32
36,Heart Development WP1591,0.02236663259909065,2.359552715654952,8.966736947201971,"['FOXC1', 'HEY1', 'HEY2', 'BHLHE40', 'SMYD1', 'VEGFC', 'NFATC2', 'NFATC1', 'TBX2', 'NFATC4', 'FGF10']",0.3545529097714032,0,0,11
37,Gastric acid production WP2596,0.023281072740926653,12.85564053537285,48.3386813768622,"['CCK', 'VIP', 'MUC6']",0.3545529097714032,0,0,3
38,Oxidation by Cytochrome P450 WP43,0.023390643352974517,2.0716782638421756,7.780020314360791,"['CYP4A11', 'CYP3A43', 'CYP3A4', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'CYP26B1', 'CYP2A6', 'CYP11A1', 'CYP1B1']",0.3545529097714032,0,0,14
39,Pregnane X receptor pathway WP2876,0.02601574690101211,2.5733716475095787,9.390370236216448,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.37343450703475844,0,0,9
40,Tamoxifen metabolism WP691,0.026218290734687084,4.286670918367347,15.609046208027543,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.37343450703475844,0,0,5
41,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.027564604041492632,5.714589310381468,20.522363375974464,"['CD86', 'IL5', 'CD80', 'VIP']",0.37343450703475844,0,0,4
42,COVID-19 adverse outcome pathway WP4891,0.027564604041492632,5.714589310381468,20.522363375974464,"['IL7', 'IL1B', 'CCL3', 'CCL2']",0.37343450703475844,0,0,4
43,Cancer immunotherapy by PD-1 blockade WP4585,0.028526247065155157,3.0014677728142947,10.676012763734423,"['JUN', 'CD8B', 'NFATC2', 'NFATC1', 'PDCD1LG2', 'BATF', 'NFATC4']",0.37343450703475844,0,0,7
44,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.028526247065155157,3.0014677728142947,10.676012763734423,"['JUN', 'TIFA', 'TLR9', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.37343450703475844,0,0,7
45,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.033847530218844166,1.474407535068116,4.99218061544132,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'ATP1A3', 'RORA', 'GATA2', 'FOXM1', 'PKNOX1', 'TAC1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'RUNX3', 'GCK', 'ADCYAP1', 'PRKAR1A', 'SST', 'IL1B', 'BHLHE40', 'CHRFAM7A', 'AVP', 'ALDOA', 'GAPDH', 'SLC25A4']",0.42021264469289515,0,0,35
46,Vitamin D Receptor Pathway WP2877,0.033847530218844166,1.474407535068116,4.99218061544132,"['COLEC11', 'CDKN1A', 'STEAP4', 'CDKN1B', 'COL13A1', 'HILPDA', 'ADRB2', 'CLDN2', 'CYP3A4', 'CYP3A5', 'FOXO1', 'THBD', 'SULT1C2', 'IL1RL1', 'CASP5', 'CLMN', 'MYC', 'CREG2', 'TIMP2', 'SOSTDC1', 'CA9', 'LGALS9', 'EPHB4', 'CDKN2D', 'IGFBP5', 'GADD45A', 'NFATC2', 'KLF4', 'CEACAM1', 'BCL6', 'CDK2', 'PNOC', 'S100A6', 'S100A4', 'S100A8']",0.42021264469289515,0,0,35
47,Cytokines and Inflammatory Response WP530,0.03428818454959388,3.215311004784689,10.84509758721262,"['IL5', 'CSF1', 'IL15', 'IL7', 'IL1B', 'CXCL1']",0.42021264469289515,0,0,6
48,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.03545623225983072,2.059137104506232,6.876398246953444,"['NDUFA13', 'CASP7', 'HSP90AA1', 'ACAP1', 'CASP5', 'IL1B', 'CASP1', 'CARD6', 'ERBIN', 'NLRC4', 'NOD2', 'AAMP']",0.4254747871179686,0,0,12
49,Complement Activation WP545,0.039237718444748416,2.7284040146197133,8.834890848511913,"['C1QB', 'C1QA', 'C6', 'C7', 'C9', 'MASP2', 'C1QC']",0.44240911632402163,0,0,7
50,TP53 network WP1742,0.039237718444748416,2.7284040146197133,8.834890848511913,"['CDKN1A', 'SUMO1', 'GADD45A', 'MYC', 'TNFSF10', 'PMAIP1', 'BAX']",0.44240911632402163,0,0,7
51,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.04070778327287005,3.5719600340136055,11.435044138900889,"['HSD11B1', 'HSD11B2', 'STAR', 'CYP11A1', 'HSD3B1']",0.44240911632402163,0,0,5
52,Glycolysis in senescence WP5049,0.04070778327287005,3.5719600340136055,11.435044138900889,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.44240911632402163,0,0,5
53,Role of Osx and miRNAs in tooth development WP3971,0.04070778327287005,3.5719600340136055,11.435044138900889,"['NOTCH3', 'ALPL', 'KLF4', 'BMP7', 'DKK1']",0.44240911632402163,0,0,5
54,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.042085361627871444,2.4502302676576537,7.762464994391866,"['GSK3A', 'BCL2L10', 'BCL2A1', 'ITGB4', 'MYC', 'BAX', 'BCL2L14', 'BCL2L2']",0.4489105240306287,0,0,8
55,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.04351966993133859,2.270283975659229,7.116301065633479,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'RAB25', 'HSPB1', 'NEFL', 'RABAC1', 'RAB11A']",0.4525088616359447,0,0,9
56,Monoamine GPCRs WP58,0.04399391710349462,2.144362823379112,6.6983545192695,"['HRH1', 'CHRM1', 'HTR1E', 'HTR1B', 'ADRA1D', 'ADRB2', 'DRD2', 'HTR5A', 'DRD3', 'DRD5']",0.4525088616359447,0,0,10
57,Development and heterogeneity of the ILC family WP3893,0.04821967154444117,2.857841573631047,8.664941979750102,"['IL5', 'NFIL3', 'IL15', 'IL7', 'IL1B', 'RORA']",0.47887122085513995,0,0,6
58,Drug Induction of Bile Acid Pathway WP2289,0.04821967154444117,2.857841573631047,8.664941979750102,"['ABCC3', 'ABCC2', 'SLC10A1', 'NR1I3', 'SLC51A', 'CYP3A4']",0.47887122085513995,0,0,6
59,Aryl Hydrocarbon Receptor Pathway WP2873,0.05429263204329666,2.0420982190384938,5.949381053744194,"['HSP90AA1', 'JUN', 'CDKN1B', 'SERPINB2', 'CDC37', 'IL1B', 'MYOF', 'AIP', 'CYP1B1', 'BAX']",0.5300433229989641,0,0,10
60,Allograft Rejection WP2328,0.05736501846610974,1.6577522989174718,4.738387538772996,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'CD80', 'CXCR5', 'CXCL13', 'HLA-E', 'CASP7', 'C6', 'IL5', 'C7', 'IL1B', 'C9', 'VIM', 'C1QC']",0.5497068492764495,0,0,17
61,EDA signaling in hair follicle development WP3930,0.05916983447072893,3.0614522594752187,8.655776900913171,"['EDA', 'SOSTDC1', 'LTB', 'DKK1', 'RELB']",0.5497068492764495,0,0,5
62,Transcriptional cascade regulating adipogenesis WP4211,0.05916983447072893,3.0614522594752187,8.655776900913171,"['CEBPB', 'EGR2', 'DDIT3', 'GATA2', 'KLF15']",0.5497068492764495,0,0,5
63,Myometrial relaxation and contraction pathways WP289,0.06429493100180883,1.3789971466885638,3.7843466837323034,"['RYR1', 'OXTR', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'RXFP2', 'ETS2', 'RYR3', 'ACTG1', 'RGS4', 'GNG3', 'RGS20', 'SFN', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP2', 'GNG12', 'GNG11', 'CREB3', 'ACTA1', 'ADCY9', 'ACTC1', 'PRKAR1A', 'IL1B', 'CRH', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.5878393691593949,0,0,35
64,Estrogen Receptor Pathway WP2881,0.07216441162683375,3.428243544788014,9.012194976494099,"['JUN', 'PDK4', 'CYP1B1', 'PPARA']",0.629798501470549,0,0,4
65,Fatty Acid Omega Oxidation WP206,0.07216441162683375,3.428243544788014,9.012194976494099,"['CYP2A6', 'ADH1B', 'CYP4A11', 'CYP3A4']",0.629798501470549,0,0,4
66,Irinotecan pathway WP229,0.07216441162683375,3.428243544788014,9.012194976494099,"['ABCC2', 'CYP3A4', 'CYP3A5', 'ABCG2']",0.629798501470549,0,0,4
67,Folate Metabolism WP176,0.08113127685000208,1.6894811284197473,4.243447338233467,"['ABCA1', 'SERPINA3', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'APOA1', 'PLG', 'F2', 'F7', 'RFK', 'IL1B', 'CCL2']",0.685429435321431,0,0,13
68,Farnesoid X receptor pathway WP2879,0.08162401091376034,2.6785714285714284,6.7115137738430475,"['SLC10A1', 'SLCO2B1', 'CYP3A4', 'IP6K3', 'FKBP5']",0.685429435321431,0,0,5
69,Cell migration and invasion through p75NTR WP4561,0.08210873443954642,1.9293103448275861,4.82271806057269,"['NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'MMP2', 'PARD3', 'CDH11']",0.685429435321431,0,0,9
70,IL-18 signaling pathway WP4754,0.08551556365969633,1.2621640850621763,3.103733287786308,"['SPON1', 'HSPB1', 'RND2', 'EPS8', 'PPP1R13L', 'TMSB4X', 'FAM186B', 'STMN1', 'NPPA', 'TGM2', 'TICAM2', 'USP5', 'IMP3', 'MMP2', 'NDUFC1', 'BPGM', 'ARL4D', 'ACTA1', 'IL1B', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'TSHZ1', 'COX17', 'GATA1', 'ACACB', 'FUT1', 'SOCS3', 'CCL3', 'HMOX1', 'CCL2', 'FADD', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'NFATC4', 'NR4A1', 'COL1A2', 'NACA', 'CYCS', 'BAX', 'PTX3', 'PTPN7', 'NFKBIE', 'IL18R1', 'CDK5R2', 'SNTB1', 'ITM2C']",0.6992067209905611,0,0,52
71,let-7 inhibition of ES cell reprogramming WP3299,0.08618693956654487,4.284576163161249,10.50251001777418,"['EGR1', 'MYC', 'KLF4']",0.6992067209905611,0,0,3
72,Oxidative Damage WP3941,0.08975177431692079,1.7469056916341261,4.211278621627239,"['C1QB', 'C1QA', 'CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'C5AR1', 'CYCS', 'TNFRSF1B', 'NFKBIE', 'C1QC']",0.7081783836513201,0,0,11
73,Vitamin B12 metabolism WP1533,0.08975177431692079,1.7469056916341261,4.211278621627239,"['ABCA1', 'SERPINA3', 'CUBN', 'F7', 'TCN1', 'IL1B', 'APOA1', 'CCL2', 'PLG', 'LRP2', 'F2']",0.7081783836513201,0,0,11
74,"COVID-19, thrombosis and anticoagulation WP4927",0.09395794054053203,8.567696718700223,20.261814836360088,"['PLG', 'F2']",0.7313482939371142,0,0,2
75,Metapathway biotransformation Phase I and II WP702,0.0953914342538162,1.3440481990321218,3.1581994220612244,"['GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST11', 'CYP11A1', 'CYP1B1', 'CHST13', 'GAL3ST2', 'SULT4A1', 'CHST8', 'GPX4', 'GPX3', 'EPHX1', 'CYP3A43', 'KCNAB1', 'FMO2', 'CYP4F11', 'HS3ST4', 'CYP39A1', 'CYP26A1', 'SULT1B1', 'CYP2A6', 'NAT8L', 'CHST2', 'CHST3']",0.7326062150693085,0,0,31
76,Toll-like Receptor Signaling related to MyD88 WP3858,0.09844366373645264,1.8373015873015872,4.259362687121493,"['TICAM2', 'TOLLIP', 'IRF7', 'TLR9', 'TLR6', 'TLR5', 'TLR4', 'RELB', 'TLR2']",0.7460993462131147,0,0,9
77,Adipogenesis WP236,0.10240359670140405,1.363107786467188,3.1062956101557204,"['CDKN1A', 'CEBPB', 'EPAS1', 'UCP1', 'LPL', 'RORA', 'GATA2', 'FOXO1', 'SOCS3', 'CYP26B1', 'NDN', 'GDF10', 'WWTR1', 'EGR2', 'GADD45B', 'GADD45A', 'EBF1', 'HMGA1', 'MIF', 'PRLR', 'KLF15', 'SFRP4', 'CYP26A1', 'DDIT3', 'LEP', 'PPARA', 'LPIN3']",0.749493978701545,0,0,27
78,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.10247289497760498,1.9051672163705358,4.340269943682417,"['ABCA1', 'ABCC3', 'CYP26A1', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP3A4', 'PPARA']",0.749493978701545,0,0,8
79,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.10279518110663552,2.8566571033896504,6.4989429119188316,"['SOCS3', 'MYC', 'CHI3L1', 'BAX']",0.749493978701545,0,0,4
80,Inflammatory Response Pathway WP453,0.10589463126964752,2.0002339927674964,4.4911468342422785,"['CD86', 'IL4R', 'COL1A2', 'IL5', 'LAMB2', 'CD80', 'TNFRSF1B']",0.7502150450798422,0,0,7
81,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.10589463126964752,2.0002339927674964,4.4911468342422785,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'EPHX1', 'HMOX1', 'ABCG2']",0.7502150450798422,0,0,7
82,TYROBP causal network in microglia WP3945,0.10742575690517815,1.5316241659811718,3.4169850559905726,"['CD84', 'RBM47', 'GIMAP2', 'RNASE6', 'SLC1A5', 'LHFPL2', 'TNFRSF1B', 'RUNX3', 'SAMSN1', 'LYL1', 'ELF4', 'HCLS1', 'TMEM106A', 'IL13RA1', 'C1QC']",0.7502150450798422,0,0,15
83,Nanomaterial induced apoptosis WP2507,0.10810390406532447,2.1429027113237638,4.7672351737623035,"['CASP7', 'ENDOG', 'CASP6', 'BAX', 'CYCS', 'FADD']",0.7502150450798422,0,0,6
84,Apoptosis WP254,0.11593460041824791,1.429745889387145,3.080714982482687,"['JUN', 'CRADD', 'BAD', 'TNFRSF10B', 'TNFRSF1B', 'CASP7', 'CASP6', 'CASP10', 'MYC', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'PMAIP1', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.7949801171536999,0,0,19
85,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.1282825099270769,1.6487728177284229,3.385788514513965,"['CREB3', 'STAR', 'CYP11A1', 'CREB3L1', 'HSD3B1', 'ITPR2', 'CALM3', 'REN', 'CALM1', 'CALM2']",0.842343171968297,0,0,10
86,Benzo(a)pyrene metabolism WP696,0.13015371927982367,3.213193116634799,6.551826307738496,"['EPHX1', 'CYP1B1', 'CYP3A4']",0.842343171968297,0,0,3
87,Codeine and Morphine Metabolism WP1604,0.13015371927982367,3.213193116634799,6.551826307738496,"['ABCC3', 'ABCC2', 'CYP3A4']",0.842343171968297,0,0,3
88,Nanomaterial-induced inflammasome activation WP3890,0.13015371927982367,3.213193116634799,6.551826307738496,"['IL1B', 'CASP1', 'TLR4']",0.842343171968297,0,0,3
89,Peroxiredoxin 2 induced ovarian failure WP4873,0.13015371927982367,3.213193116634799,6.551826307738496,"['STAR', 'CYP11A1', 'BAX']",0.842343171968297,0,0,3
90,ERK Pathway in Huntington's Disease WP3853,0.13777273762817566,2.1425382653061225,4.2468317514738985,"['CASP7', 'RPS6KA5', 'BDNF', 'ELK1', 'HRAS']",0.8533021169228944,0,0,5
91,Galanin receptor pathway WP4970,0.13777273762817566,2.1425382653061225,4.2468317514738985,"['YAP1', 'POMC', 'CDKN1A', 'CDKN1B', 'UCP1']",0.8533021169228944,0,0,5
92,Major receptors targeted by epinephrine and norepinephrine WP4589,0.13777273762817566,2.1425382653061225,4.2468317514738985,"['ADCY10', 'ADCY9', 'ADCY4', 'ADRA1D', 'ADRB2']",0.8533021169228944,0,0,5
93,Selective expression of chemokine receptors during T-cell polarization WP4494,0.13777273762817566,2.1425382653061225,4.2468317514738985,"['IL4R', 'IL5', 'CCL3', 'CXCR4', 'IL18R1']",0.8533021169228944,0,0,5
94,Circadian rhythm related genes WP3594,0.14922311228466764,1.2306291955853907,2.3410415417662476,"['TPH1', 'MAGEL2', 'AHCY', 'CHRM1', 'SUV39H1', 'NPY2R', 'OPRL1', 'RORA', 'RELB', 'ATOH7', 'PROKR2', 'NFIL3', 'SIX3', 'RPS27A', 'DRD2', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'JUN', 'EGR3', 'CARTPT', 'HCRTR2', 'HCRTR1', 'PER2', 'F7', 'STAR', 'ADORA2A', 'LEP', 'BHLHE40', 'CRH', 'UTS2', 'GHRL', 'AVP', 'PPARA', 'UBA52']",0.9143884327230698,0,0,39
95,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.162233203326386,1.8365003417634997,3.340080731980563,"['H3F3B', 'BCL6', 'H2AFZ', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9801373865900718,0,0,6
96,Aflatoxin B1 metabolism WP699,0.1646348466545287,4.283529786556228,7.727596142842606,"['EPHX1', 'CYP3A4']",0.9801373865900718,0,0,2
97,Exercise-induced Circadian Regulation WP410,0.16505785850561971,1.4697164771949047,2.647634282370311,"['PER2', 'DNAJA1', 'IDI1', 'HSPA8', 'CLDN5', 'CEBPB', 'BTG1', 'SUMO1', 'STBD1', 'UCP3', 'SUMO3', 'EIF4G2']",0.9801373865900718,0,0,12
98,Differentiation Pathway WP2848,0.16818800304305456,1.5307751973354018,2.7288713983371964,"['CSF1R', 'CNTF', 'TPO', 'CSF1', 'HGF', 'FST', 'FGF2', 'DKK1', 'NODAL', 'FGF10']",0.9885335689061167,0,0,10
99,Serotonin and anxiety WP3947,0.17077664163265285,1.9476171150278294,3.4422160849051413,"['POMC', 'GABRA1', 'ARC', 'CRH', 'TRPV1']",0.993609551317253,0,0,5
100,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.17782565923617685,2.142174051641696,3.699431015534737,"['HLA-DRB5', 'CD8B', 'IGLL1', 'CD247']",0.999948212053341,0,0,4
101,Dual hijack model of Vif in HIV infection WP3300,0.1800587637381973,2.570363288718929,4.406815929868171,"['ELOB', 'ELOC', 'RUNX1']",0.999948212053341,0,0,3
102,HIF1A and PPARG regulation of glycolysis WP2456,0.1800587637381973,2.570363288718929,4.406815929868171,"['LDHA', 'TPI1', 'GAPDH']",0.999948212053341,0,0,3
103,NAD Biosynthesis II (from tryptophan) WP2485,0.1800587637381973,2.570363288718929,4.406815929868171,"['KYNU', 'HAAO', 'KMO']",0.999948212053341,0,0,3
104,G1 to S cell cycle control WP45,0.18298091190034074,1.3681749499734552,2.3236719937587034,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'GADD45A', 'MYT1', 'CREB3', 'CCND3', 'TFDP2', 'MYC', 'CREB3L1', 'RPA3', 'POLE2', 'CDK2', 'CDK1', 'MCM4']",0.999948212053341,0,0,15
105,DNA damage response WP707,0.18745705445609961,1.344953725490196,2.2517289281017034,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CDK2', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.999948212053341,0,0,16
106,Globo Sphingolipid Metabolism WP1424,0.1928898191521311,1.7139393939393939,2.820520605550748,"['B3GALNT1', 'B3GALT5', 'FUT2', 'A4GALT', 'FUT1', 'ABO']",0.999948212053341,0,0,6
107,IL1 and megakaryocytes in obesity WP2865,0.1928898191521311,1.7139393939393939,2.820520605550748,"['IL1R1', 'IL1B', 'TIMP2', 'CCL2', 'F2', 'TLR2']",0.999948212053341,0,0,6
108,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.1928898191521311,1.7139393939393939,2.820520605550748,"['CD86', 'IL4R', 'CD80', 'CCL2', 'TLR4', 'TGFBR2']",0.999948212053341,0,0,6
109,Base Excision Repair WP4752,0.19390662397663552,1.5583089110060064,2.5562165204562963,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLE3']",0.999948212053341,0,0,8
110,Genes controlling nephrogenesis WP4823,0.20464349110800006,1.48342175066313,2.3534276638014586,"['FOXC1', 'FOXD1', 'EYA1', 'LAMB2', 'ITGA8', 'CXCR4', 'ETV4', 'GLI3', 'PAX2']",0.999948212053341,0,0,9
111,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.20464349110800006,1.48342175066313,2.3534276638014586,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'BCL2A1', 'IGFBP2', 'PGK1', 'PMAIP1', 'BAX']",0.999948212053341,0,0,9
112,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.20645503813523874,1.7851828231292517,2.8164340676178354,"['TCF7L1', 'VCAM1', 'EPAS1', 'LEF1', 'CXCR4']",0.999948212053341,0,0,5
113,Purinergic signaling WP4900,0.20884349147218015,1.5786618748530548,2.4724531087671195,"['P2RY8', 'P2RX7', 'ADORA2A', 'GNAT3', 'ADORA3', 'P2RY14', 'P2RX1']",0.999948212053341,0,0,7
114,Vitamin A and carotenoid metabolism WP716,0.21323443047154622,1.4285105929947834,2.207567566887443,"['CYP26A1', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'LPL', 'LRAT', 'BCO1']",0.999948212053341,0,0,10
115,VEGFA-VEGFR2 Signaling Pathway WP3888,0.21725546957050776,1.10909924569137,1.6932411212348721,"['FLT1', 'ARPC5L', 'HSPB1', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'RND1', 'TUBB8', 'TUBA1C', 'CDH5', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'CFL1', 'RPLP2', 'ELOC', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'ADAMTS9', 'CLIC1', 'HRAS', 'CGNL1', 'PRKG1', 'DUSP5', 'HSP90AA1', 'SSR4', 'MMP2', 'GAB1', 'SARS', 'DKK1', 'EPN1', 'RCN1', 'TAL1', 'RHOJ', 'TXNIP', 'PRKD2', 'RPL27', 'PRKD1', 'RPL26', 'ERG', 'ATP6V0D1', 'ALDOA', 'DSC1', 'GAPDH', 'FJX1', 'ARF6', 'EPHA2', 'KANK1', 'SET', 'TXN', 'ADRB2', 'GATA2', 'ACACB', 'FUT1', 'APOLD1', 'FOXO1', 'LDHA', 'PGK1', 'CCL2', 'DNAJB9', 'IGFBP7', 'FADD', 'CCT7', 'MAPK3', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'BMX', 'SELE', 'RAB11A', 'DNAJA1', 'FMNL3', 'MOV10', 'NR4A1', 'NR4A3', 'CYCS', 'EIF4G2', 'HSPA1A']",0.999948212053341,0,0,85
116,miRNA regulation of DNA damage response WP1530,0.22247056417830582,1.2940075471698114,1.9448422067484537,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CDK2', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.999948212053341,0,0,16
117,Cardiac Progenitor Differentiation WP2406,0.2300971519916395,1.4283737760749255,2.0986433973191647,"['MESP1', 'PDGFRA', 'ACTC1', 'CXCR4', 'PAX6', 'THY1', 'FGF2', 'DKK1', 'NODAL']",0.999948212053341,0,0,9
118,Bile acids synthesis and enterohepatic circulation  WP4389,0.23400594529408164,2.1418100701083493,3.110783701029733,"['SLC10A1', 'FGFR4', 'MAPK3']",0.999948212053341,0,0,3
119,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.23400594529408164,2.1418100701083493,3.110783701029733,"['CYP4A11', 'PPARA', 'CYP2C18']",0.999948212053341,0,0,3
120,Tgif disruption of Shh signaling WP3674,0.23400594529408164,2.1418100701083493,3.110783701029733,"['TGIF2', 'NODAL', 'GLI3']",0.999948212053341,0,0,3
121,Trans-sulfuration pathway WP2333,0.23400594529408164,2.1418100701083493,3.110783701029733,"['AHCY', 'GOT1', 'MAT2B']",0.999948212053341,0,0,3
122,Aryl Hydrocarbon Receptor Netpath WP2586,0.2374183704090233,1.3823265781312783,1.9876908168083283,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'MYC', 'CDC37', 'CDK2', 'AIP', 'LPL', 'CYP1B1', 'HRAS']",0.999948212053341,0,0,10
123,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.23902871507983692,1.499617102744097,2.1462093895615917,"['CNTF', 'IL1B', 'CXCL1', 'FGF2', 'MYT1', 'GLI2', 'SOX5']",0.999948212053341,0,0,7
124,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.23902871507983692,1.499617102744097,2.1462093895615917,"['VCAM1', 'BCL2A1', 'MMP2', 'IL1B', 'SELE', 'BCL2L2', 'RELB']",0.999948212053341,0,0,7
125,miR-517 relationship with ARCN1 and USP1 WP3596,0.24103496626672,2.8554741425082297,4.062806495740904,"['CDKN1A', 'ARCN1']",0.999948212053341,0,0,2
126,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.24103496626672,2.8554741425082297,4.062806495740904,"['MAS1', 'REN']",0.999948212053341,0,0,2
127,Apoptosis Modulation by HSP70 WP384,0.24428239817570105,1.6477384222919937,2.322372546763058,"['CASP7', 'CASP6', 'CYCS', 'FADD', 'HSPA1A']",0.999948212053341,0,0,5
128,Nicotine Activity on Dopaminergic Neurons WP1602,0.24428239817570105,1.6477384222919937,2.322372546763058,"['CHRNB2', 'CDK5', 'DRD2', 'DRD3', 'SLC18A2']",0.999948212053341,0,0,5
129,Proteoglycan biosynthesis WP4784,0.24428239817570105,1.6477384222919937,2.322372546763058,"['CSGALNACT1', 'XYLT1', 'B3GALT6', 'B4GALT7', 'CHST3']",0.999948212053341,0,0,5
130,PI3K-Akt signaling pathway WP4172,0.2505393905101575,1.114244405383646,1.542269274380432,"['CDKN1A', 'CDKN1B', 'CHRM1', 'FLT1', 'CSF1', 'ITGB4', 'FGF2', 'GYS2', 'GYS1', 'CCND3', 'MYC', 'CREB3L1', 'TNR', 'ITGB8', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'SYK', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'COL6A6', 'TLR4', 'EPHA2', 'TLR2', 'CSF1R', 'PKN3', 'LAMA1', 'LPAR3', 'PIK3R5', 'GNG10', 'GNG3', 'PDGFC', 'MAPK3', 'NTRK1', 'NGFR', 'ANGPT2', 'LAMB3', 'BDNF', 'LAMB2', 'BAD', 'VEGFC', 'GNG12', 'GNG11', 'FGF17', 'EFNA3', 'COL1A2', 'IL7', 'ITGA10', 'CDK2', 'COL9A1', 'FGFR4', 'PIK3AP1', 'FGF10']",0.999948212053341,0,0,60
131,Regulation of toll-like receptor signaling pathway WP1449,0.2530420346431702,1.1908073028098702,1.6364069897185782,"['CD86', 'CD80', 'PELI3', 'PELI2', 'LY96', 'PIK3R5', 'TIFA', 'CCL3', 'FADD', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'SYK', 'CD180', 'IRAK3', 'SMAD6', 'TOLLIP', 'IL1B', 'IRF7', 'TLR9', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.999948212053341,0,0,25
132,Calcium Regulation in the Cardiac Cell WP536,0.25436476077025444,1.1658881931516896,1.5960845861201707,"['RYR1', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'ADRA1D', 'ADRB2', 'RYR3', 'RGS4', 'GNG3', 'PLN', 'GJA4', 'RGS20', 'SFN', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG12', 'GNG11', 'GJD2', 'SLC8A3', 'GJB2', 'ADCY9', 'PRKAR1A', 'CALM3', 'PRKD1', 'CASQ1', 'CALM1', 'CALM2']",0.999948212053341,0,0,31
133,DNA Mismatch Repair WP531,0.2597422476998282,1.5120743034055728,2.038375193820371,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.999948212053341,0,0,6
134,Zinc homeostasis WP3529,0.2597422476998282,1.5120743034055728,2.038375193820371,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.999948212053341,0,0,6
135,Cells and molecules involved in local acute inflammatory response  WP4493,0.26564604900068145,1.7134842205929233,2.2713784032551794,"['SELP', 'VCAM1', 'C6', 'C7']",0.999948212053341,0,0,4
136,Hedgehog Signaling Pathway Netpath WP47,0.26564604900068145,1.7134842205929233,2.2713784032551794,"['SMO', 'SUFU', 'GLI3', 'GLI2']",0.999948212053341,0,0,4
137,Phytochemical activity on NRF2 transcriptional activation WP3,0.26564604900068145,1.7134842205929233,2.2713784032551794,"['AIMP2', 'CEBPB', 'HMOX1', 'SLC7A11']",0.999948212053341,0,0,4
138,Netrin-UNC5B signaling pathway WP4747,0.2671989700055864,1.3093006744763933,1.7279648736101687,"['YAP1', 'CDH5', 'DCSTAMP', 'JUN', 'VCAM1', 'ITGB4', 'INPP5D', 'CCL2', 'ALPL', 'SELE', 'MAPK3']",0.999948212053341,0,0,11
139,Hippo-Merlin Signaling Dysregulation WP4541,0.26789594923892385,1.1824809443209099,1.5575126073457084,"['NTRK1', 'PDGFRA', 'CSF1R', 'NGFR', 'FLT1', 'ITGB4', 'FOXM1', 'CDH5', 'CDH4', 'LATS2', 'PRKAR1A', 'CDH20', 'MYC', 'ITGA10', 'CDH11', 'ITGA8', 'ITGB8', 'FGFR4', 'HRAS', 'CDH17', 'TEAD2', 'CD44', 'EPHA2', 'TEAD3']",0.999948212053341,0,0,24
140,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.27049441994776,1.4281004041693257,1.8672467188959976,"['GGT5', 'CYSLTR2', 'HPGD', 'TRPA1', 'CYP4A11', 'TRPV1', 'PPARA']",0.999948212053341,0,0,7
141,Ovarian infertility WP34,0.27049441994776,1.4281004041693257,1.8672467188959976,"['EGR1', 'CEBPB', 'CDKN1B', 'GJA4', 'PGR', 'BMPR1B', 'PRLR']",0.999948212053341,0,0,7
142,Phosphodiesterases in neuronal function WP4222,0.2709051623687852,1.285522531160115,1.6788750373438823,"['ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE6H', 'ADCY4', 'PDE3A', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'PDE6A', 'DRD2']",0.999948212053341,0,0,12
143,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.276250852102779,1.2498667519454216,1.6078860106059403,"['CDKN1A', 'JUN', 'CDKN1B', 'FZD2', 'WNT16', 'ELK1', 'ACTA1', 'MYC', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NEFH', 'PFN2']",0.999948212053341,0,0,14
144,CAMKK2  Pathway WP4874,0.27828358829412886,1.3710054261091607,1.7536730345449207,"['FIS1', 'MAP1LC3A', 'VCAM1', 'HMOX1', 'NFATC2', 'CALM1', 'CALM2', 'MAPK3']",0.999948212053341,0,0,8
145,GDNF/RET signaling axis WP4830,0.28371355360550066,1.5299289358600583,1.9273894248311572,"['FOXC1', 'EYA1', 'SPRY1', 'PAX2', 'GLI3']",0.999948212053341,0,0,5
146,PPAR-alpha pathway WP2878,0.28371355360550066,1.5299289358600583,1.9273894248311572,"['MYC', 'CYP4A11', 'CDK1', 'APOA1', 'PPARA']",0.999948212053341,0,0,5
147,Ferroptosis WP4313,0.28407904000250417,1.329667063020214,1.673389681555187,"['PRNP', 'MAP1LC3A', 'GPX4', 'FTH1', 'HMOX1', 'SAT2', 'SLC7A11', 'CP', 'FTL']",0.999948212053341,0,0,9
148,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.29023912630094795,1.8357006282436492,2.2708536867190405,"['MYOCD', 'KLF4', 'ELK1']",0.999948212053341,0,0,3
149,Unfolded protein response WP4925,0.2952026132988726,1.4279638490164805,1.7422491728875515,"['XBP1', 'IL1B', 'DDIT3', 'TNFRSF10B', 'PMAIP1', 'TXNIP']",0.999948212053341,0,0,6
150,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2963630076414911,1.2378445581131003,1.5054296624193402,"['HMGCS1', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'ALPL', 'CALM1', 'CALM2', 'SOX5']",0.999948212053341,0,0,13
151,Endochondral Ossification WP474,0.2963630076414911,1.2378445581131003,1.5054296624193402,"['HMGCS1', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'ALPL', 'CALM1', 'CALM2', 'SOX5']",0.999948212053341,0,0,13
152,Pyrimidine metabolism WP4022,0.3006597006275696,1.1866991797827533,1.426146850403525,"['CDA', 'POLR2J2', 'NME2', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLD1', 'POLE2', 'POLE3', 'POLR2E', 'CMPK2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.999948212053341,0,0,18
153,Pathways Regulating Hippo Signaling WP4540,0.30083045271002057,1.1741055948874835,1.410345565256116,"['NTRK1', 'PDGFRA', 'CSF1R', 'NGFR', 'TCF7L1', 'PRKCH', 'FLT1', 'LEF1', 'PRKAG2', 'CDH5', 'CDH4', 'LATS2', 'PRKAR1A', 'CDH20', 'CDH11', 'FGFR4', 'CDH17', 'TEAD2', 'EPHA2', 'TEAD3']",0.999948212053341,0,0,20
154,Airway smooth muscle cell contraction WP4962,0.3121454290312742,1.5575970093024605,1.813488517866186,"['RYR1', 'ADRB2', 'CALM1', 'CALM2']",0.999948212053341,0,0,4
155,miRNAs involved in DNA damage response WP1545,0.3121454290312742,1.5575970093024605,1.813488517866186,"['CDKN1A', 'CCND3', 'CDKN1B', 'MYC']",0.999948212053341,0,0,4
156,Microglia Pathogen Phagocytosis Pathway WP3937,0.31226721890789677,1.2852490421455938,1.4958962022893412,"['C1QB', 'LYN', 'C1QA', 'SYK', 'NCF4', 'RAC3', 'FCGR1A', 'SIGLEC7', 'C1QC']",0.999948212053341,0,0,9
157,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.31845897005241797,2.1414463204842304,2.450374867320208,"['COX8A', 'COX5A']",0.999948212053341,0,0,2
158,Composition of Lipid Particles WP3601,0.31845897005241797,2.1414463204842304,2.450374867320208,"['APOA1', 'LPL']",0.999948212053341,0,0,2
159,FTO Obesity Variant Mechanism WP3407,0.31845897005241797,2.1414463204842304,2.450374867320208,"['PRDM16', 'UCP1']",0.999948212053341,0,0,2
160,Senescence and Autophagy in Cancer WP615,0.31896330184491184,1.1581527057336094,1.3233970351232165,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'CDKN1B', 'SERPINB2', 'IGFBP5', 'HMGA1', 'CXCL1', 'GABARAP', 'MAP1LC3A', 'IFI16', 'IL1B', 'IRF7', 'CCL3', 'IGFBP7', 'HRAS', 'CD44', 'SLC39A3']",0.999948212053341,0,0,20
161,Canonical and non-canonical Notch signaling WP3845,0.3315175632984668,1.3527071266683455,1.4934894302749555,"['NOTCH3', 'MAML2', 'HEY1', 'LEF1', 'DLL3', 'DLK2']",0.999948212053341,0,0,6
162,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3410186684484399,1.2436967000370782,1.3379913673486499,"['ACTA1', 'CASP7', 'JUN', 'CASP6', 'CASP10', 'HSPB1', 'CYCS', 'FADD', 'ACTG1']",0.999948212053341,0,0,9
163,Nephrotic syndrome WP4758,0.3410186684484399,1.2436967000370782,1.3379913673486499,"['CUBN', 'TRPC6', 'ITGB4', 'LAMB2', 'ARHGDIA', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.999948212053341,0,0,9
164,Breast cancer pathway WP4262,0.34177846706965964,1.1095987881013587,1.1912569468024161,"['NOTCH3', 'CDKN1A', 'LEF1', 'FGF2', 'DLL3', 'FRAT1', 'FRAT2', 'HEY1', 'MYC', 'HEY2', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'GADD45B', 'GADD45A', 'CSNK2A3', 'WNT16', 'FGF17', 'SFRP4', 'HEYL', 'RAD51', 'BAX', 'PGR', 'FGF10']",0.999948212053341,0,0,29
165,Prader-Willi and Angelman Syndrome WP3998,0.3428912890185489,1.1955673482128921,1.2796657358300414,"['POMC', 'PCSK1', 'GABRR2', 'GABRR1', 'MAGEL2', 'BDNF', 'NDN', 'ATP10A', 'GHRL', 'CGA', 'TYR', 'GABRD']",0.999948212053341,0,0,12
166,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.34722614590676987,1.6061185468451242,1.6989184607269054,"['TPO', 'CSF1', 'IKZF1']",0.999948212053341,0,0,3
167,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.34722614590676987,1.6061185468451242,1.6989184607269054,"['IDI1', 'HMGCS1', 'IDI2']",0.999948212053341,0,0,3
168,Serotonin Transporter Activity WP1455,0.34722614590676987,1.6061185468451242,1.6989184607269054,"['IL1R1', 'IL1B', 'TGFB1I1']",0.999948212053341,0,0,3
169,Glutathione metabolism WP100,0.35926834764349364,1.4276909998937413,1.4615068366969657,"['GGT5', 'GPX4', 'GPX3', 'GGT2']",0.999948212053341,0,0,4
170,MAPK pathway in congenital thyroid cancer WP4928,0.35926834764349364,1.4276909998937413,1.4615068366969657,"['JUN', 'MYC', 'ELK1', 'MAPK3']",0.999948212053341,0,0,4
171,Type II diabetes mellitus WP1584,0.35926834764349364,1.4276909998937413,1.4615068366969657,"['SURF1', 'KCNJ11', 'SLC2A2', 'PIK3R5']",0.999948212053341,0,0,4
172,Toll-like Receptor Signaling Pathway WP75,0.3607591285764643,1.138004161331626,1.160246199127819,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'TOLLIP', 'IL1B', 'IRF7', 'TLR9', 'CCL3', 'FADD', 'TLR6', 'TLR5', 'TLR4', 'TLR2', 'MAPK3']",0.999948212053341,0,0,17
173,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.36227181487194543,1.1424426666666667,1.159991133377876,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'LEF1', 'WNT16', 'KLF4', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'MYC']",0.999948212053341,0,0,16
174,7-oxo-C and 7beta-HC pathways WP5064,0.3683197762251648,1.284976076555024,1.2834389380636892,"['HSD11B1', 'HSD11B2', 'ACOT11', 'THEM5', 'ACOT6', 'ACOT4']",0.999948212053341,0,0,6
175,IL-3 signaling pathway WP286,0.36960042427801076,1.1898931828666737,1.184339703024072,"['CD86', 'LYN', 'JUN', 'SYK', 'YWHAB', 'BAD', 'INPP5D', 'CSF2RB', 'HRAS', 'MAPK3']",0.999948212053341,0,0,10
176,Tryptophan metabolism WP465,0.3702879409510206,1.2238384022616389,1.2158520700189202,"['TPH1', 'HAAO', 'KYNU', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.999948212053341,0,0,8
177,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.388126663003401,1.1315324230228503,1.0709089232242748,"['YAP1', 'ANGPT2', 'BAD', 'MMP2', 'TIE1', 'FOXO1', 'CASP7', 'RAD51', 'MYC', 'STMN1', 'BAX', 'HRAS', 'ANGPTL1', 'MAPK3']",0.999948212053341,0,0,14
178,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.39378104764426347,1.713029627269831,1.5964755039122507,"['IL1B', 'CASP1']",0.999948212053341,0,0,2
179,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.39378104764426347,1.713029627269831,1.5964755039122507,"['CEBPB', 'ALDH1L1']",0.999948212053341,0,0,2
180,LDLRAD4 and what we know about it WP4904,0.39378104764426347,1.713029627269831,1.5964755039122507,"['NEDD4', 'TGFBR2']",0.999948212053341,0,0,2
181,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.39378104764426347,1.713029627269831,1.5964755039122507,"['HEY1', 'VEGFC']",0.999948212053341,0,0,2
182,"Phase I biotransformations, non P450 WP136",0.39378104764426347,1.713029627269831,1.5964755039122507,"['PON3', 'PON2']",0.999948212053341,0,0,2
183,The alternative pathway of fetal androgen synthesis WP4524,0.39378104764426347,1.713029627269831,1.5964755039122507,"['STAR', 'CYP11A1']",0.999948212053341,0,0,2
184,Metabolic reprogramming in colon cancer WP4290,0.3995057589688346,1.1681469871125043,1.0718065156348027,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'SLC1A5', 'ALDOB', 'GAPDH']",0.999948212053341,0,0,9
185,Alpha 6 Beta 4 signaling pathway WP244,0.40360572470310707,1.1992469687300575,1.0880969298758594,"['LAMB3', 'LAMA1', 'ITGB4', 'LAMB2', 'GAB1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,7
186,Melatonin metabolism and effects WP3298,0.40360572470310707,1.1992469687300575,1.0880969298758594,"['PER2', 'EDN1', 'CYP1B1', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.999948212053341,0,0,7
187,ACE Inhibitor Pathway WP554,0.40369295711574155,1.4275547057573825,1.294935868758151,"['MAS1', 'ATP6AP2', 'REN']",0.999948212053341,0,0,3
188,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.40369295711574155,1.4275547057573825,1.294935868758151,"['SST', 'DKK1', 'FOXO1']",0.999948212053341,0,0,3
189,Iron metabolism in placenta WP2007,0.40369295711574155,1.4275547057573825,1.294935868758151,"['HEPHL1', 'FTH1', 'HAMP']",0.999948212053341,0,0,3
190,LTF danger signal response pathway WP4478,0.40369295711574155,1.4275547057573825,1.294935868758151,"['IL1B', 'TLR4', 'TLR2']",0.999948212053341,0,0,3
191,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.40369295711574155,1.4275547057573825,1.294935868758151,"['MYC', 'PGR', 'VIM']",0.999948212053341,0,0,3
192,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.40369295711574155,1.4275547057573825,1.294935868758151,"['JUN', 'RYR3', 'MAPK3']",0.999948212053341,0,0,3
193,Purine metabolism WP4792,0.40369295711574155,1.4275547057573825,1.294935868758151,"['PRPS1', 'XDH', 'APRT']",0.999948212053341,0,0,3
194,RalA downstream regulated genes WP2290,0.40369295711574155,1.4275547057573825,1.294935868758151,"['RAC3', 'YBX3', 'HRAS']",0.999948212053341,0,0,3
195,Sulfation Biotransformation Reaction WP692,0.40369295711574155,1.4275547057573825,1.294935868758151,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.999948212053341,0,0,3
196,Alzheimer's disease WP2059,0.40511753195988137,1.1054245161290324,0.9988373304814685,"['ATP5MD', 'BAD', 'ITPR2', 'LPL', 'RYR3', 'CASP7', 'CDK5', 'IL1B', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.999948212053341,0,0,16
197,Striated Muscle Contraction Pathway WP383,0.4052600685310935,1.223695602642971,1.105274019001291,"['MYOM1', 'ACTA1', 'ACTC1', 'VIM', 'MYL9', 'ACTG1']",0.999948212053341,0,0,6
198,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.40628781286441557,1.3177705303940561,1.1869073141216606,"['HSPB1', 'PDLIM5', 'TLR4', 'ETS2']",0.999948212053341,0,0,4
199,miR-509-3p alteration of YAP1/ECM axis WP3967,0.40628781286441557,1.3177705303940561,1.1869073141216606,"['YAP1', 'PBX3', 'TEAD2', 'TEAD3']",0.999948212053341,0,0,4
200,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.40628781286441557,1.3177705303940561,1.1869073141216606,"['EIF1AX', 'EIF3I', 'EIF3CL', 'EIF1']",0.999948212053341,0,0,4
201,Endometrial cancer WP4155,0.41447407253046237,1.1136445012787723,0.9808366676471172,"['CDKN1A', 'TCF7L1', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'FGF2', 'ELK1', 'MYC', 'BAX', 'CTNNA2', 'HRAS', 'MAPK3']",0.999948212053341,0,0,13
202,TGF-beta Receptor Signaling WP560,0.42502832045300576,1.1270991275698028,0.9643454228561444,"['TGFBR3', 'JUN', 'FST', 'LEF1', 'ZNF423', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.999948212053341,0,0,10
203,Prostaglandin Synthesis and Regulation WP98,0.4288986762040448,1.1337052062204191,0.9597206537383505,"['HSD11B1', 'HSD11B2', 'EDN1', 'HPGD', 'CYP11A1', 'ANXA3', 'TBXAS1', 'S100A6', 'PTGDR']",0.999948212053341,0,0,9
204,Acute viral myocarditis WP4298,0.43045948410923923,1.0889261199128144,0.9178580839389017,"['EDN1', 'ENDOG', 'CD80', 'CXCR4', 'NOD2', 'CASP7', 'CASP6', 'CASP1', 'RAC3', 'CYCS', 'BAX', 'TLR5', 'TLR4', 'EIF4G2', 'MAPK3']",0.999948212053341,0,0,15
205,IL-2 signaling pathway WP49,0.4329915117161444,1.142078944568571,0.9559625100887804,"['SOCS3', 'JUN', 'SYK', 'CISH', 'MYC', 'NMI', 'HRAS', 'MAPK3']",0.999948212053341,0,0,8
206,Neural Crest Cell Migration during Development WP4564,0.4329915117161444,1.142078944568571,0.9559625100887804,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'EPHB4', 'PIK3R5']",0.999948212053341,0,0,8
207,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4373462883978294,1.1530361788817436,0.9535954830295431,"['YAP1', 'FYB1', 'LATS2', 'LPL', 'FOXO1', 'TEAD2', 'TEAD3']",0.999948212053341,0,0,7
208,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4385734671756473,1.0917268441903616,0.8998317669386289,"['EGR1', 'JUN', 'CDKN1B', 'KCNIP3', 'TSHR', 'MYL12B', 'CCND3', 'MYC', 'APEX1', 'CDK2', 'CGA', 'HRAS', 'MAPK3']",0.999948212053341,0,0,13
209,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.444014558923174,1.070742637644046,0.8693337275539007,"['BAD', 'UCP1', 'DIO3', 'ITPR2', 'TRH', 'FOXO1', 'TSHR', 'MC4R', 'POMC', 'CREB3', 'TPO', 'NHSL1', 'TG', 'NPPA', 'ZNF516', 'PRDM16', 'HRAS']",0.999948212053341,0,0,17
210,IL-7 signaling pathway WP205,0.4470626379130617,1.1895904195011338,0.9576875764360318,"['CDKN1B', 'BAD', 'IL7', 'MYC', 'MAPK3']",0.999948212053341,0,0,5
211,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4470626379130617,1.1895904195011338,0.9576875764360318,"['GOT1', 'MDH2', 'SCO2', 'IL1B', 'HMGA1']",0.999948212053341,0,0,5
212,RAS and bradykinin pathways in COVID-19 WP4969,0.4470626379130617,1.1895904195011338,0.9576875764360318,"['F12', 'IL1B', 'REN', 'CYP3A4', 'PRKG1']",0.999948212053341,0,0,5
213,BMP Signaling Pathway in Eyelid Development WP3927,0.4525750559862198,1.2235529851086115,0.9700348377094228,"['FOXC1', 'JUN', 'MAPK3', 'FGF10']",0.999948212053341,0,0,4
214,Methionine De Novo and Salvage Pathway WP3580,0.4525750559862198,1.2235529851086115,0.9700348377094228,"['AHCY', 'ODC1', 'TXN', 'MAT2B']",0.999948212053341,0,0,4
215,Nucleotide metabolism WP404,0.4525750559862198,1.2235529851086115,0.9700348377094228,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.999948212053341,0,0,4
216,Transcription co-factors SKI and SKIL protein partners WP4533,0.4525750559862198,1.2235529851086115,0.9700348377094228,"['LATS2', 'MERTK', 'TEAD2', 'TEAD3']",0.999948212053341,0,0,4
217,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.45862623570251926,1.2847036328871893,1.0014517929980542,"['RYR1', 'CCK', 'RYR3']",0.999948212053341,0,0,3
218,Cysteine and methionine catabolism WP4504,0.45862623570251926,1.2847036328871893,1.0014517929980542,"['AHCY', 'GOT1', 'SQOR']",0.999948212053341,0,0,3
219,Homologous recombination WP186,0.45862623570251926,1.2847036328871893,1.0014517929980542,"['POLD4', 'RAD51', 'POLD1']",0.999948212053341,0,0,3
220,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.45862623570251926,1.2847036328871893,1.0014517929980542,"['ABCA1', 'LPL', 'APOA1']",0.999948212053341,0,0,3
221,Osteoclast Signaling WP12,0.45862623570251926,1.2847036328871893,1.0014517929980542,"['AIMP2', 'ATP6V1G1', 'GPR68']",0.999948212053341,0,0,3
222,IL-5 signaling pathway WP127,0.4641461562509504,1.1051553185136374,0.8482683574245452,"['LYN', 'GSK3A', 'JUN', 'SYK', 'MYC', 'CSF2RB', 'ELK1', 'MAPK3']",0.999948212053341,0,0,8
223,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.4650217771146685,1.4274184984602314,1.0929330090671714,"['TLR4', 'TLR2']",0.999948212053341,0,0,2
224,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.4650217771146685,1.4274184984602314,1.0929330090671714,"['ELOB', 'ELOC']",0.999948212053341,0,0,2
225,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.46718174960958425,1.0225254399477197,0.7781796028162571,"['CDKN1A', 'CDKN1B', 'CHRM1', 'FLT1', 'CSF1', 'ITGB4', 'SLC2A2', 'HIF3A', 'FGF2', 'GYS2', 'GYS1', 'CREB3L1', 'TNR', 'ITGB8', 'PELO', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'EPHA2', 'CSF1R', 'EPAS1', 'LAMA1', 'LPAR3', 'FOXO1', 'PIK3R5', 'GNG10', 'GNG3', 'PDGFC', 'MAPK3', 'NGFR', 'ANGPT2', 'LAMB3', 'LAMB2', 'BAD', 'VEGFC', 'GNG12', 'GNG11', 'FGF17', 'EFNA3', 'COL1A2', 'COL5A3', 'ITGA10', 'FGFR4', 'FGF10']",0.999948212053341,0,0,53
226,Nicotine Metabolism WP1600,0.4672854704827159,2.141082802547771,1.6289677459342609,['CYP2A6'],0.999948212053341,0,0,1
227,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4707784396730863,1.1102484105036754,0.836425291151758,"['JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'DOCK1', 'MAPK3']",0.999948212053341,0,0,7
228,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.4782885276191709,1.1171208654046183,0.8239225679078486,"['OAS2', 'IRF7', 'TLR9', 'TLR6', 'TLR4', 'TLR2']",0.999948212053341,0,0,6
229,Mesodermal commitment pathway WP2857,0.48404860314106807,1.0294262861656958,0.7469207867996775,"['YAP1', 'FOXC1', 'LEF1', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2', 'TCF7L1', 'SLC2A12', 'PBX3', 'PAX6', 'ZIC5', 'TBX6', 'ELP4', 'SMAD6', 'KLF4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'TBX3', 'ARL4A', 'PRKAR1A', 'BHLHE40', 'NODAL']",0.999948212053341,0,0,25
230,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4865279674032446,1.050372774212228,0.7567525058983182,"['HSPA8', 'UBE2L6', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'PSMD7', 'TUBB2A', 'PSMD2', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.999948212053341,0,0,13
231,Physiological and pathological hypertrophy of the heart WP1528,0.4870257845690036,1.1268964822771215,0.8107323898387275,"['EDN1', 'JUN', 'CALM1', 'CALM2', 'NFATC4']",0.999948212053341,0,0,5
232,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.4870257845690036,1.1268964822771215,0.8107323898387275,"['GSK3A', 'CD8B', 'NFATC2', 'CALM1', 'CALM2']",0.999948212053341,0,0,5
233,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.48718244476543626,1.0705619412515963,0.7698588591577117,"['PDGFRA', 'CDKN1A', 'HSP90AA1', 'JUN', 'MMP2', 'TNFSF10', 'BAX', 'BMF', 'ELK1']",0.999948212053341,0,0,9
234,ATM Signaling Pathway WP2516,0.4949280151924457,1.070539419087137,0.7529563540136046,"['CDKN1A', 'JUN', 'RAD51', 'CRADD', 'GADD45A', 'CDK2', 'CDK1', 'RAD9A']",0.999948212053341,0,0,8
235,Copper homeostasis WP3286,0.4949280151924457,1.070539419087137,0.7529563540136046,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'COX17', 'XAF1', 'FOXO1', 'ATOX1']",0.999948212053341,0,0,8
236,Hepatitis B infection WP4666,0.4963663509621988,1.0214381433431017,0.7154571689483916,"['CDKN1A', 'YWHAB', 'ELK1', 'CASP10', 'MYC', 'CREB3L1', 'FADD', 'HRAS', 'MAPK3', 'JUN', 'EGR2', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'BAD', 'NFATC2', 'NFATC1', 'NFATC4', 'TGFBR2', 'CREB3', 'IRF7', 'CYCS', 'BAX', 'TLR4', 'TLR2']",0.999948212053341,0,0,26
237,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.49760476848085106,1.1418977791945595,0.7969865896777605,"['CASP7', 'BAD', 'BAX', 'FADD']",0.999948212053341,0,0,4
238,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.49760476848085106,1.1418977791945595,0.7969865896777605,"['EGR1', 'RPS6KA5', 'ELK1', 'MAPK3']",0.999948212053341,0,0,4
239,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5034627719807271,1.0336005646041706,0.7093037445531262,"['CDKN1A', 'TCF7L1', 'JUN', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'TGFBR2', 'MYC', 'RAC3', 'PMAIP1', 'CYCS', 'BAX', 'MAPK3']",0.999948212053341,0,0,14
240,TNF-alpha signaling pathway WP231,0.5063881922103785,1.0252700582496257,0.697646780284683,"['HSP90AA1', 'JUN', 'BAD', 'TXN', 'TNFRSF1B', 'SELE', 'CASP7', 'PSMD2', 'RFK', 'CDC37', 'CCL2', 'BAX', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.999948212053341,0,0,17
241,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.507406833193394,1.0443947620568508,0.7085614433106643,"['BEX3', 'SOCS3', 'CDKN1A', 'CASP7', 'CDKN1B', 'HSPB1', 'TNFRSF10B', 'RNF7', 'VIM', 'YBX3']",0.999948212053341,0,0,10
242,Pathogenic Escherichia coli infection WP2272,0.507406833193394,1.0443947620568508,0.7085614433106643,"['TUBB8', 'TUBA1C', 'TUBB2A', 'ARPC5L', 'HCLS1', 'LY96', 'TLR5', 'TLR4', 'TUBA4A', 'ACTG1']",0.999948212053341,0,0,10
243,Nephrogenesis WP5052,0.511257168381384,1.167825482357031,0.7834737380719735,"['FOXD1', 'BMP7', 'PAX2']",0.999948212053341,0,0,3
244,GABA receptor Signaling WP4159,0.5138220778262342,1.0704944178628388,0.7128189234174896,"['GABRA1', 'SLC32A1', 'GAD1', 'GABRE', 'GABRD', 'AP2M1']",0.999948212053341,0,0,6
245,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5138220778262342,1.0704944178628388,0.7128189234174896,"['FKBP10', 'ADAMTS2', 'COL1A2', 'P4HA1', 'CREB3L1', 'SERPINH1']",0.999948212053341,0,0,6
246,Development of ureteric collection system WP5053,0.5251757025854038,1.0380214529592122,0.668509068205603,"['FOXC1', 'SMO', 'ITGA8', 'SPRY1', 'ETV4', 'GLI3', 'PAX2', 'GLI2']",0.999948212053341,0,0,8
247,DNA Replication WP466,0.5251757025854038,1.0380214529592122,0.668509068205603,"['POLD4', 'CDT1', 'POLD1', 'RPA3', 'POLE2', 'CDK2', 'MCM4', 'UBA52']",0.999948212053341,0,0,8
248,Neural Crest Cell Migration in Cancer WP4565,0.5251757025854038,1.0380214529592122,0.668509068205603,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'EPHB4', 'PIK3R5']",0.999948212053341,0,0,8
249,Estrogen metabolism WP697,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['CYP1B1', 'CYP3A4']",0.999948212053341,0,0,2
250,FOXP3 in COVID-19 WP5063,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['CD86', 'CD80']",0.999948212053341,0,0,2
251,Leptin and adiponectin WP3934,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['LEP', 'LEPR']",0.999948212053341,0,0,2
252,Macrophage markers WP4146,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['CD86', 'CD163']",0.999948212053341,0,0,2
253,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['AHCY', 'MAT2B']",0.999948212053341,0,0,2
254,Nucleotide GPCRs WP80,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['ADORA2A', 'ADORA3']",0.999948212053341,0,0,2
255,PTF1A related regulatory pathway WP4147,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['KAT2B', 'FGF10']",0.999948212053341,0,0,2
256,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['TBX6', 'DLL3']",0.999948212053341,0,0,2
257,Thiamine metabolic pathways WP4297,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['BCKDK', 'SLC19A3']",0.999948212053341,0,0,2
258,Vitamin B12 Disorders WP4271,0.5310262621190197,1.2234105493105174,0.7743501234010407,"['CUBN', 'TCN1']",0.999948212053341,0,0,2
259,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.534170320758786,1.0194521756323098,0.6392378408213122,"['TGFBR3', 'JUN', 'FST', 'LEF1', 'ZNF423', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.999948212053341,0,0,10
260,One-carbon metabolism WP241,0.5409541870131501,1.070449474019764,0.6577062999064858,"['ALDH1L1', 'AHCY', 'DNMT3A', 'MAT2B']",0.999948212053341,0,0,4
261,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5409541870131501,1.070449474019764,0.6577062999064858,"['CD86', 'LDHA', 'CD80', 'MYC']",0.999948212053341,0,0,4
262,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5483895533771033,1.0275980861244018,0.6173494658621831,"['TICAM2', 'SYK', 'LY96', 'CCL2', 'PLG', 'TLR4']",0.999948212053341,0,0,6
263,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5483895533771033,1.0275980861244018,0.6173494658621831,"['PDGFRA', 'EDA', 'SMO', 'MYC', 'LEF1', 'GLI2']",0.999948212053341,0,0,6
264,Leptin signaling pathway WP2034,0.5483976218837936,0.9989979746295704,0.6001526963476871,"['GSK3A', 'CISH', 'BAD', 'ELK1', 'ACACB', 'FOXO1', 'SOCS3', 'CFL2', 'IL1B', 'LEP', 'LEPR', 'BAX', 'HRAS', 'MAPK3']",0.999948212053341,0,0,14
265,22q11.2 copy number variation syndrome WP4657,0.5529106270745091,0.9919923126201153,0.5878138787472145,"['RANBP1', 'FOXC1', 'VWF', 'SERPIND1', 'GP1BA', 'RTN4', 'SLC7A4', 'CLDN5', 'CYP26A1', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'RCC1', 'DRD2', 'PRODH', 'RAN', 'FGF10']",0.999948212053341,0,0,19
266,Androgen receptor signaling pathway WP138,0.5543552426967544,0.992760579710145,0.5856786725778536,"['CDKN1A', 'JUN', 'TGFB1I1', 'DSTN', 'RNF6', 'ETV5', 'FOXO1', 'KAT2B', 'SUMO1', 'KAT5', 'BAG1', 'BMF', 'STUB1', 'FKBP4', 'RAN', 'RAD9A']",0.999948212053341,0,0,16
267,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5547450855374685,1.0074163083682244,0.5936166103997822,"['CDKN1A', 'CASP7', 'JUN', 'MYC', 'MYOF', 'LEF1', 'CD44', 'MAPK3']",0.999948212053341,0,0,8
268,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5547450855374685,1.0074163083682244,0.5936166103997822,"['BAD', 'IL1B', 'NPPA', 'PDE3A', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.999948212053341,0,0,8
269,Fatty acid transporters WP5061,0.5610350723086056,1.0704270235818993,0.618676695597502,"['FABP6', 'FABP7', 'ACSBG1']",0.999948212053341,0,0,3
270,ID signaling pathway WP53,0.5610350723086056,1.0704270235818993,0.618676695597502,"['CDK2', 'ELK1', 'PAX2']",0.999948212053341,0,0,3
271,Leptin Insulin Overlap WP3935,0.5610350723086056,1.0704270235818993,0.618676695597502,"['SOCS3', 'LEP', 'LEPR']",0.999948212053341,0,0,3
272,Overview of nanoparticle effects WP3287,0.5610350723086056,1.0704270235818993,0.618676695597502,"['CCND3', 'HMOX1', 'BAX']",0.999948212053341,0,0,3
273,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5610350723086056,1.0704270235818993,0.618676695597502,"['BUB1B', 'ANAPC11', 'MAD2L1']",0.999948212053341,0,0,3
274,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5610350723086056,1.0704270235818993,0.618676695597502,"['ABCA1', 'HMGCS1', 'PPARA']",0.999948212053341,0,0,3
275,Tryptophan catabolism leading to NAD+ production WP4210,0.5610350723086056,1.0704270235818993,0.618676695597502,"['HAAO', 'KYNU', 'KMO']",0.999948212053341,0,0,3
276,Cannabinoid receptor signaling WP3869,0.5634225701533087,1.0194211613216715,0.5848677765654537,"['ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.999948212053341,0,0,5
277,B Cell Receptor Signaling Pathway WP23,0.5670719523036083,0.9834844447520504,0.5579003194134651,"['LYN', 'JUN', 'GSK3A', 'SYK', 'GAB1', 'DAPP1', 'NFATC2', 'ELK1', 'FOXO1', 'PTPRC', 'BCL6', 'MYC', 'INPP5D', 'HCLS1', 'PIK3AP1', 'HRAS', 'CARD11']",0.999948212053341,0,0,17
278,Vitamin D-sensitive calcium signaling in depression WP4698,0.5672143395903021,0.9990002127206977,0.5664511253124077,"['TPH1', 'CHRM1', 'CALB1', 'GPX4', 'ITPR2', 'PVALB', 'GGT2']",0.999948212053341,0,0,7
279,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.568168937226747,1.4272823779193207,0.8068947951963046,['FMO2'],0.999948212053341,0,0,1
280,GABA metabolism (aka GHB) WP4157,0.568168937226747,1.4272823779193207,0.8068947951963046,['PON3'],0.999948212053341,0,0,1
281,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.568168937226747,1.4272823779193207,0.8068947951963046,['CHRM1'],0.999948212053341,0,0,1
282,Sulindac Metabolic Pathway WP2542,0.568168937226747,1.4272823779193207,0.8068947951963046,['CYP1B1'],0.999948212053341,0,0,1
283,Vitamin B6-dependent and responsive disorders WP4228,0.568168937226747,1.4272823779193207,0.8068947951963046,['PNPO'],0.999948212053341,0,0,1
284,Oncostatin M Signaling Pathway WP2374,0.5753084654889058,0.9810969116080938,0.5423983683011239,"['SOCS3', 'EGR1', 'CASP7', 'CEBPB', 'CDKN1B', 'PRKCH', 'CDK2', 'CCL2', 'OSMR', 'HRAS', 'MAPK3']",0.999948212053341,0,0,11
285,Matrix Metalloproteinases WP129,0.5822978263908606,1.0074068518067092,0.5447786601429759,"['MMP16', 'MMP2', 'TIMP2', 'MMP19']",0.999948212053341,0,0,4
286,Modulators of TCR signaling and T cell activation WP5072,0.5860277040923287,0.9729682645683924,0.5199427730982508,"['FIBP', 'CDKN1B', 'NDUFB10', 'CD5', 'RHOH', 'ELOB', 'RNF7', 'CD247', 'CARD11', 'ZFP36L1']",0.999948212053341,0,0,10
287,Nanoparticle triggered regulated necrosis WP2513,0.5912230029049467,1.070404587448232,0.5625639771448927,"['FADD', 'FTL']",0.999948212053341,0,0,2
288,Neuroinflammation WP4919,0.5912230029049467,1.070404587448232,0.5625639771448927,"['JUN', 'TLR4']",0.999948212053341,0,0,2
289,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5979457362341037,0.9632183908045977,0.4953401348191153,"['CD160', 'CXCL17', 'IRF7', 'CCL3', 'CCL2', 'CXCL1', 'FADD', 'CXCL13', 'CXCL5']",0.999948212053341,0,0,9
290,Synaptic Vesicle Pathway WP2267,0.5979457362341037,0.9632183908045977,0.4953401348191153,"['NSF', 'RAB3A', 'SLC32A1', 'CLTCL1', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1']",0.999948212053341,0,0,9
291,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5993685694375375,0.9730113636363636,0.4980636578048363,"['TGFBR3', 'HGF', 'HRAS', 'PIK3R5', 'TGFBR2']",0.999948212053341,0,0,5
292,Lipid Metabolism Pathway WP3965,0.5993685694375375,0.9730113636363636,0.4980636578048363,"['ACLY', 'PRKAR1A', 'HILPDA', 'PRKAG2', 'ACSBG1']",0.999948212053341,0,0,5
293,FOXA2 pathway WP5066,0.6075965901520993,0.9880129430798646,0.4922716396410272,"['ABCC3', 'ABCC2', 'FOXO1']",0.999948212053341,0,0,3
294,Hypertrophy Model WP516,0.6075965901520993,0.9880129430798646,0.4922716396410272,"['NR4A3', 'MSTN', 'IL1R1']",0.999948212053341,0,0,3
295,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6075965901520993,0.9880129430798646,0.4922716396410272,"['SFRP4', 'LEF1', 'DKK3']",0.999948212053341,0,0,3
296,Genotoxicity pathway WP4286,0.6109501712501337,0.9512757727385642,0.4687315062232431,"['IKBIP', 'PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'BLOC1S2', 'PCDH8', 'TRIAP1', 'HIST1H2BG', 'HIST1H2BC']",0.999948212053341,0,0,10
297,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6116211882174744,0.951244629096978,0.46767196567280583,"['CDKN1A', 'CDKN1B', 'CR1', 'TRPC6', 'KIRREL2', 'ITGB4', 'LAMB2', 'CD80', 'VIM', 'DKK1', 'TLR4', 'PAX2']",0.999948212053341,0,0,12
298,Type 2 papillary renal cell carcinoma WP4241,0.6139022525145847,0.951337940811625,0.46417639079287976,"['CDKN1A', 'EGLN3', 'EPAS1', 'COL21A1', 'ELOB', 'ELOC']",0.999948212053341,0,0,6
299,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6213993531947402,0.9513689653951051,0.45264358492895473,"['H3F3B', 'SUV39H1', 'LEF1', 'HIST1H3E']",0.999948212053341,0,0,4
300,"GPCRs, Class B Secretin-like WP334",0.6213993531947402,0.9513689653951051,0.45264358492895473,"['ADGRE1', 'ADGRE2', 'ADGRG2', 'GIPR']",0.999948212053341,0,0,4
301,NRF2-ARE regulation WP4357,0.6213993531947402,0.9513689653951051,0.45264358492895473,"['AIMP2', 'CEBPB', 'HMOX1', 'SLC7A11']",0.999948212053341,0,0,4
302,Statin inhibition of cholesterol production WP430,0.6213993531947402,0.9513689653951051,0.45264358492895473,"['ABCA1', 'LPL', 'APOA1', 'ACSS1']",0.999948212053341,0,0,4
303,3q29 copy number variation syndrome WP4906,0.6228144381779822,0.9417124600638977,0.44590711844640757,"['CASP7', 'TM4SF19', 'JUN', 'NCBP2', 'MYC', 'DYNLT3', 'MAD2L1BP', 'SLC51A', 'DYNLL1', 'DYNLL2', 'HAMP']",0.999948212053341,0,0,11
304,Pathways in clear cell renal cell carcinoma WP4018,0.6236662248950716,0.9441684543299086,0.4457796465565136,"['PDGFRA', 'FLT1', 'TPI1', 'ENO2', 'ACACB', 'LDHC', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'PFKM']",0.999948212053341,0,0,15
305,IL-4 signaling pathway WP395,0.6237881547547094,0.9396551724137931,0.4434650565391071,"['SOCS3', 'CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'BAD', 'INPP5D', 'ELK1', 'MAPK3']",0.999948212053341,0,0,9
306,Hedgehog Signaling Pathway WP4249,0.6266988003513904,0.9364231014677729,0.43758043564302374,"['EVC2', 'SMO', 'SUFU', 'BOC', 'LRP2', 'GLI3', 'GLI2']",0.999948212053341,0,0,7
307,IL17 signaling pathway WP2112,0.6335759888176439,0.9306372005323869,0.4247198647490679,"['CEBPB', 'IL17RE', 'IL17RD', 'IL17RB', 'MAPK3']",0.999948212053341,0,0,5
308,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6335759888176439,0.9306372005323869,0.4247198647490679,"['CEBPB', 'GJB2', 'MYC', 'PGR', 'PRLR']",0.999948212053341,0,0,5
309,Signal transduction through IL1R WP4496,0.6335759888176439,0.9306372005323869,0.4247198647490679,"['JUN', 'IL1R1', 'TOLLIP', 'IL1B', 'IRAK3']",0.999948212053341,0,0,5
310,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6432490358271916,0.9304153105788756,0.41052093857392913,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'LEF1', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'MYC']",0.999948212053341,0,0,15
311,Retinoblastoma gene in cancer WP2446,0.6432490358271916,0.9304153105788756,0.41052093857392913,"['CDT1', 'CDKN1A', 'CDKN1B', 'H2AFZ', 'SUV39H1', 'TTK', 'CCND3', 'TFDP2', 'MYC', 'RPA3', 'POLE2', 'STMN1', 'CDK2', 'CDK1', 'MCM4']",0.999948212053341,0,0,15
312,Wnt signaling WP428,0.6436998095540616,0.9346314991127114,0.4117264810178023,"['WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'LEF1', 'NFATC2', 'NFATC1', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'NFATC4', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'MYC', 'GPC4']",0.999948212053341,0,0,19
313,Amyotrophic lateral sclerosis (ALS) WP2447,0.6445716180095915,0.9172932330827067,0.40284706464159564,"['BAD', 'CASP1', 'NEFL', 'BAX', 'NEFM', 'NEFH']",0.999948212053341,0,0,6
314,p38 MAPK Signaling Pathway WP400,0.6445716180095915,0.9172932330827067,0.40284706464159564,"['RPS6KA5', 'MYC', 'DDIT3', 'HSPB1', 'ELK1', 'HRAS']",0.999948212053341,0,0,6
315,Parkinson's disease pathway WP2371,0.6445716180095915,0.9172932330827067,0.40284706464159564,"['CASP7', 'PINK1', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6']",0.999948212053341,0,0,6
316,Alanine and aspartate metabolism WP106,0.6454444799671895,0.9513999504442321,0.41653819994553254,"['GOT1', 'GAD1']",0.999948212053341,0,0,2
317,Biogenic Amine Synthesis WP550,0.6454444799671895,0.9513999504442321,0.41653819994553254,"['TPH1', 'GAD1']",0.999948212053341,0,0,2
318,"NAD metabolism, sirtuins and aging WP3630",0.6454444799671895,0.9513999504442321,0.41653819994553254,"['ROS1', 'FOXO1']",0.999948212053341,0,0,2
319,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6455266606608125,0.9231786005136879,0.40406490357148345,"['IFI27L2', 'JUN', 'PRKCH', 'OAS2', 'CCL2', 'NOD2', 'HRAS', 'TLR4', 'TLR2', 'RELB', 'MAPK3']",0.999948212053341,0,0,11
320,Benzene metabolism WP3891,0.6499523547178657,1.0703821656050956,0.46118081298575797,['EPHX1'],0.999948212053341,0,0,1
321,MED and Pseudoachondroplasia genes WP4789,0.6499523547178657,1.0703821656050956,0.46118081298575797,['COL9A1'],0.999948212053341,0,0,1
322,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6499523547178657,1.0703821656050956,0.46118081298575797,['FOXO1'],0.999948212053341,0,0,1
323,Steroid Biosynthesis WP496,0.6499523547178657,1.0703821656050956,0.46118081298575797,['HSD3B1'],0.999948212053341,0,0,1
324,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.6499523547178657,1.0703821656050956,0.46118081298575797,['MAPK3'],0.999948212053341,0,0,1
325,15q13.3 copy number variation syndrome WP4942,0.6507341487794172,0.9173723026495493,0.39415276536431876,"['KAT2B', 'SERPINH1', 'CHRFAM7A']",0.999948212053341,0,0,3
326,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6507341487794172,0.9173723026495493,0.39415276536431876,"['CDKN1A', 'ALPL', 'ROS1']",0.999948212053341,0,0,3
327,Glycogen Synthesis and Degradation WP500,0.6546501579545351,0.9079789599891706,0.38466918710200565,"['GYS2', 'GYS1', 'GSK3A', 'PYGM', 'CALM3', 'CALM1', 'CALM2']",0.999948212053341,0,0,7
328,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6581017888452543,0.9012298038689328,0.3770706434023078,"['BDNF', 'CGA', 'FOXO1', 'MAPK3']",0.999948212053341,0,0,4
329,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6581017888452543,0.9012298038689328,0.3770706434023078,"['TGFBR3', 'ANGPT2', 'MAPK3', 'TGFBR2']",0.999948212053341,0,0,4
330,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6581017888452543,0.9012298038689328,0.3770706434023078,"['PTGES2', 'HRAS', 'MAPK3', 'PLA1A']",0.999948212053341,0,0,4
331,Cell cycle WP179,0.6606946266377492,0.9264175257731959,0.383966280590534,"['CDKN2D', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'YWHAB', 'TTK', 'CDC14A', 'ANAPC11', 'CCND3', 'TFDP2', 'PTTG2', 'MYC', 'CDK2', 'CDK1', 'MCM4', 'SFN', 'YWHAG', 'SKP1', 'YWHAH']",0.999948212053341,0,0,21
332,miRNAs involvement in the immune response in sepsis WP4329,0.6659275163169313,0.8917942176870748,0.3625807424310153,"['VCAM1', 'CCL3', 'IRF7', 'TLR4', 'RELB']",0.999948212053341,0,0,5
333,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6737196337156918,0.885596436231645,0.3497585443268852,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'DDIT3', 'MAPK3']",0.999948212053341,0,0,6
334,Osteoblast differentiation WP4787,0.6773288588749751,0.9134917835729042,0.3558949052892981,"['NOTCH3', 'WNT10A', 'PRKCH', 'FZD2', 'WNT8A', 'WNT16', 'FGF2', 'GLI3', 'PIK3R5', 'GLI2', 'DLL3', 'SMO', 'HEY1', 'HEY2', 'PRKD1', 'BMPR1B', 'FGFR4', 'FGF10', 'MAPK3']",0.999948212053341,0,0,19
335,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6903659288293366,0.8561504142766093,0.3172324012495893,"['RAB27A', 'HRAS', 'MAPK3']",0.999948212053341,0,0,3
336,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6903659288293366,0.8561504142766093,0.3172324012495893,"['SUV39H1', 'CDC37', 'IGFBP7']",0.999948212053341,0,0,3
337,Angiogenesis WP1539,0.6923169573808436,0.8561045584953777,0.31479940346613927,"['PDGFRA', 'FLT1', 'TIMP2', 'FGF2']",0.999948212053341,0,0,4
338,TLR4 Signaling and Tolerance WP3851,0.6923169573808436,0.8561045584953777,0.31479940346613927,"['INPP5D', 'IRF7', 'IRAK3', 'TLR4']",0.999948212053341,0,0,4
339,Biomarkers for urea cycle disorders WP4583,0.6937947350737343,0.8561962408410322,0.31300747941416857,"['F7', 'GOT1']",0.999948212053341,0,0,2
340,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6937947350737343,0.8561962408410322,0.31300747941416857,"['BMPR1B', 'SMAD6']",0.999948212053341,0,0,2
341,Cancer immunotherapy by CTLA4 blockade WP4582,0.6937947350737343,0.8561962408410322,0.31300747941416857,"['CD86', 'CD80']",0.999948212053341,0,0,2
342,Genes targeted by miRNAs in adipocytes WP1992,0.6937947350737343,0.8561962408410322,0.31300747941416857,"['TMSB4X', 'ERG']",0.999948212053341,0,0,2
343,Serotonin and anxiety-related events WP3944,0.6937947350737343,0.8561962408410322,0.31300747941416857,"['ARC', 'CRH']",0.999948212053341,0,0,2
344,7q11.23 copy number variation syndrome WP4932,0.6956366139677764,0.8980216879277912,0.32591709065528884,"['ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5F1E', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'MYC', 'CFL1', 'BCL7B', 'EIF4H', 'GTF2IRD1', 'GAPDH', 'PRKG1', 'MAPK3']",0.999948212053341,0,0,17
345,Endothelin Pathways WP2197,0.6963485758187896,0.8560586734693878,0.30981184290712976,"['ADCY10', 'EDN1', 'RIIAD1', 'CALM1', 'CALM2']",0.999948212053341,0,0,5
346,Oxysterols derived from cholesterol WP4545,0.7012855817392174,0.8560127591706539,0.30374763849982184,"['CYP39A1', 'ACOT11', 'THEM5', 'CYP3A4', 'ACOT6', 'ACOT4']",0.999948212053341,0,0,6
347,Eukaryotic Transcription Initiation WP405,0.7066189296504208,0.8559668155711551,0.2972462502288465,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.999948212053341,0,0,7
348,Melanoma WP4685,0.708949019596981,0.8716956573186605,0.29983860199592965,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'BAX', 'CALM3', 'CALM1', 'ELK1', 'HRAS', 'CALM2', 'MAPK3']",0.999948212053341,0,0,11
349,Effects of nitric oxide WP1995,0.716250955478461,0.8562420382165605,0.28574909759717376,['XDH'],0.999948212053341,0,0,1
350,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.716250955478461,0.8562420382165605,0.28574909759717376,['GGT2'],0.999948212053341,0,0,1
351,Hfe effect on hepcidin production WP3924,0.716250955478461,0.8562420382165605,0.28574909759717376,['HAMP'],0.999948212053341,0,0,1
352,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.716250955478461,0.8562420382165605,0.28574909759717376,['CDKN1A'],0.999948212053341,0,0,1
353,Metastatic brain tumor WP2249,0.716250955478461,0.8562420382165605,0.28574909759717376,['MYC'],0.999948212053341,0,0,1
354,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.716250955478461,0.8562420382165605,0.28574909759717376,['SIX4'],0.999948212053341,0,0,1
355,miRNA Biogenesis WP2338,0.716250955478461,0.8562420382165605,0.28574909759717376,['RAN'],0.999948212053341,0,0,1
356,Photodynamic therapy-induced unfolded protein response WP3613,0.7240148546358024,0.8152769555383518,0.2632882869783366,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9']",0.999948212053341,0,0,4
357,Fluoropyrimidine Activity WP1601,0.7248022046929349,0.8230720172684458,0.26491106429183453,"['ABCC3', 'CDA', 'CYP2A6', 'UPP2', 'ABCG2']",0.999948212053341,0,0,5
358,miRNA regulation of prostate cancer signaling pathways WP3981,0.7248022046929349,0.8230720172684458,0.26491106429183453,"['CDKN1A', 'CDKN1B', 'BAD', 'CREB3L1', 'FOXO1']",0.999948212053341,0,0,5
359,Prion disease pathway WP3995,0.7248022046929349,0.8230720172684458,0.26491106429183453,"['PRNP', 'EBF1', 'ELK1', 'MAPK3', 'BATF']",0.999948212053341,0,0,5
360,Tumor suppressor activity of SMARCB1 WP4204,0.7248022046929349,0.8230720172684458,0.26491106429183453,"['H3F3B', 'SMO', 'DPF3', 'GLI3', 'GLI2']",0.999948212053341,0,0,5
361,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7265086060908392,0.8025812619502868,0.2564286860351513,"['ELK1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,3
362,Transcription factor regulation in adipogenesis WP3599,0.7265086060908392,0.8025812619502868,0.2564286860351513,"['CEBPB', 'LEP', 'FOXO1']",0.999948212053341,0,0,3
363,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7272348283108232,0.8283377064361784,0.2638303999318839,"['NGFR', 'GABRA1', 'SLC12A5', 'BDNF', 'GABRE', 'GABRD']",0.999948212053341,0,0,6
364,Neovascularisation processes WP4331,0.7272348283108232,0.8283377064361784,0.2638303999318839,"['ACVRL1', 'NOTCH3', 'CXCR4', 'EPHB4', 'RELB', 'MAPK3']",0.999948212053341,0,0,6
365,Integrated Cancer Pathway WP1971,0.730556760738092,0.8321279160462313,0.2612451858940039,"['CDKN1A', 'CDKN1B', 'BAD', 'MYC', 'CDK2', 'CDK1', 'BAX']",0.999948212053341,0,0,7
366,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.730556760738092,0.8321279160462313,0.2612451858940039,"['ACTA1', 'ACTC1', 'ITGB4', 'ITGB8', 'TEAD2', 'ACTG1', 'TEAD3']",0.999948212053341,0,0,7
367,DNA damage response (only ATM dependent) WP710,0.7335911203455194,0.8750327482315955,0.27108817505546556,"['WNT10A', 'JUN', 'CDKN1A', 'TCF7L1', 'CDKN1B', 'MLKL', 'BAD', 'LEF1', 'WNT16', 'PIK3R5', 'FRAT1', 'CCND3', 'BCL6', 'MYC', 'PMAIP1', 'RAC3', 'BAX', 'HRAS']",0.999948212053341,0,0,18
368,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7343752888827807,0.8349824449409512,0.2577883788489185,"['RPS6KA5', 'IL1R1', 'MYC', 'TOLLIP', 'MKNK2', 'IRF7', 'ELK1', 'MAPK3']",0.999948212053341,0,0,8
369,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7343752888827807,0.8349824449409512,0.2577883788489185,"['JUN', 'IL5', 'PTPRC', 'NFATC2', 'CALM1', 'CALM2', 'CARD11', 'MAPK3']",0.999948212053341,0,0,8
370,Ganglio Sphingolipid Metabolism WP1423,0.7365525925545062,0.7783022966202323,0.2379851021203876,"['B3GALT1', 'FUT1']",0.999948212053341,0,0,2
371,Cytosolic DNA-sensing pathway WP4655,0.7384695855069221,0.8372063968015993,0.253820352424478,"['CASP10', 'IL1B', 'CASP1', 'IRF7', 'POLR2E', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.999948212053341,0,0,9
372,PPAR signaling pathway WP3942,0.7384695855069221,0.8372063968015993,0.253820352424478,"['FABP6', 'FABP7', 'CYP4A11', 'UCP1', 'APOA1', 'LPL', 'ACSBG1', 'ANGPTL4', 'PPARA']",0.999948212053341,0,0,9
373,Endoderm differentiation WP2853,0.7493592681750502,0.8720593726661687,0.2516211743023839,"['DUSP4', 'DUSP5', 'DUSP2', 'TCF7L1', 'ONECUT1', 'SLC2A12', 'LEF1', 'PBX3', 'WNT8A', 'ZIC5', 'ELP4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'FOXO1', 'GLI2', 'NME1', 'ZIC3', 'TCEAL2', 'NODAL']",0.999948212053341,0,0,21
374,BDNF-TrkB Signaling WP3676,0.7512838446391477,0.7925288170823885,0.22664084723612843,"['ARC', 'TRPC6', 'BDNF', 'GAB1', 'HRAS']",0.999948212053341,0,0,5
375,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7515558252217491,0.8023923444976077,0.22917110699494286,"['PRKCH', 'STAR', 'CYP11A1', 'HSD3B1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,6
376,Nucleotide Excision Repair WP4753,0.7531070433124828,0.809577605684817,0.22955403442511843,"['POLE4', 'POLD4', 'CETN2', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.999948212053341,0,0,7
377,Ethanol effects on histone modifications WP3996,0.7532134169638393,0.7781609528501463,0.22053600365227474,"['KAT2B', 'ALDH1A3', 'AHCY', 'ADH1B']",0.999948212053341,0,0,4
378,Gastric Cancer Network 2 WP2363,0.7532134169638393,0.7781609528501463,0.22053600365227474,"['PLAC8', 'MYC', 'S100A6', 'COL9A1']",0.999948212053341,0,0,4
379,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7592534619974047,0.7553143628388258,0.20802839124904876,"['FCGR2A', 'IL1B', 'NFKBIE']",0.999948212053341,0,0,3
380,Neural Crest Differentiation WP2064,0.7598614240056812,0.8435299999549584,0.2316495330565601,"['NOTCH3', 'TCF7L1', 'MIA', 'WNT8A', 'ZIC5', 'TBX6', 'FGF2', 'BMP7', 'DLL3', 'MYC', 'HEY2', 'ZIC1', 'HES5', 'SOX5']",0.999948212053341,0,0,14
381,"Cerebral organic acidurias, including diseases WP4519",0.7699958633613682,0.7134819532908705,0.18648287545542605,['MDH2'],0.999948212053341,0,0,1
382,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7699958633613682,0.7134819532908705,0.18648287545542605,['DHCR24'],0.999948212053341,0,0,1
383,Glial Cell Differentiation WP2276,0.7699958633613682,0.7134819532908705,0.18648287545542605,['MSN'],0.999948212053341,0,0,1
384,Mevalonate pathway WP3963,0.7699958633613682,0.7134819532908705,0.18648287545542605,['HMGCS1'],0.999948212053341,0,0,1
385,Molybdenum cofactor (Moco) biosynthesis WP4507,0.7699958633613682,0.7134819532908705,0.18648287545542605,['XDH'],0.999948212053341,0,0,1
386,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7741017768122974,0.7133906764362323,0.18266505201747205,"['TULP3', 'PMAIP1']",0.999948212053341,0,0,2
387,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7741017768122974,0.7133906764362323,0.18266505201747205,"['MYC', 'ALPL']",0.999948212053341,0,0,2
388,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7742570748291738,0.778019428737132,0.19905729978541678,"['CASP7', 'JUN', 'CCL2', 'FADD', 'RELB', 'MAPK3']",0.999948212053341,0,0,6
389,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7742719027907161,0.7882141537634769,0.2016505385541141,"['ADCY10', 'ADCY9', 'CFL1', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,7
390,Cardiac Hypertrophic Response WP2795,0.7752929462786302,0.7960272864258197,0.20260034816505734,"['NPPA', 'NFATC2', 'PRKD1', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'MAPK3']",0.999948212053341,0,0,8
391,Translation Factors WP107,0.7752929462786302,0.7960272864258197,0.20260034816505734,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF1AX', 'EIF3I', 'EIF4H', 'EIF3CL', 'EIF1']",0.999948212053341,0,0,8
392,MAPK Cascade WP422,0.7758162407677112,0.7641672740524781,0.19397590751825336,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.999948212053341,0,0,5
393,Focal Adhesion WP306,0.7760792197052678,0.8769907052312971,0.22231773728872342,"['FLT1', 'ITGB4', 'LAMA1', 'ELK1', 'MYL12B', 'ACTG1', 'CCND3', 'PDGFC', 'RAC3', 'TNR', 'ITGB8', 'HRAS', 'MAPK3', 'PDGFRA', 'JUN', 'CAV3', 'VWF', 'LAMB3', 'CAV2', 'LAMB2', 'BAD', 'HGF', 'VEGFC', 'FGR', 'COL1A2', 'PARVG', 'COL5A3', 'ITGA10', 'COL4A6', 'ITGA8', 'MYL9', 'DOCK1']",0.999948212053341,0,0,32
394,Notch Signaling Pathway Netpath WP61,0.7769799687926492,0.8022030651340997,0.20242849032736854,"['NOTCH3', 'CDKN1A', 'MAML2', 'HEY1', 'MYC', 'HEY2', 'HES5', 'SKP1', 'DLL3']",0.999948212053341,0,0,9
395,Intraflagellar transport proteins binding to dynein WP4532,0.7799690069325602,0.7442724286565675,0.18495251334301266,"['IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2']",0.999948212053341,0,0,4
396,Monoamine Transport WP727,0.7799690069325602,0.7442724286565675,0.18495251334301266,"['ADORA2A', 'IL1R1', 'TGFB1I1', 'IL1B']",0.999948212053341,0,0,4
397,miRNA targets in ECM and membrane receptors WP2911,0.7887460252771678,0.7132993414064159,0.16927371182254577,"['COL1A2', 'LAMB2', 'COL5A3']",0.999948212053341,0,0,3
398,Purine metabolism and related disorders WP4224,0.7887460252771678,0.7132993414064159,0.16927371182254577,"['PRPS1', 'XDH', 'APRT']",0.999948212053341,0,0,3
399,Urea cycle and metabolism of amino groups WP497,0.7887460252771678,0.7132993414064159,0.16927371182254577,"['CKM', 'ODC1', 'PYCR3']",0.999948212053341,0,0,3
400,Small cell lung cancer WP4658,0.7928764790589207,0.822506028840002,0.19089364234992592,"['CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMA1', 'LAMB2', 'GADD45A', 'FHIT', 'MYC', 'CDK2', 'CKS2', 'COL4A6', 'CYCS', 'BAX', 'SKP1']",0.999948212053341,0,0,15
401,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7953641496713739,0.7550802139037434,0.17287955596307392,"['LYN', 'CISH', 'MYC', 'RELB', 'MAPK3', 'CRLF2']",0.999948212053341,0,0,6
402,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7975233829082529,0.7975253154275194,0.18043541674897426,"['TCF7L1', 'ITGB4', 'ITGA10', 'LEF1', 'ITGA8', 'ITGB8', 'CTNNA2', 'CACNG1', 'CACNG4', 'ACTG1', 'CACNG5']",0.999948212053341,0,0,11
403,Corticotropin-releasing hormone signaling pathway WP2355,0.8016104086838527,0.8058443604284814,0.17819842948625328,"['HSP90AA1', 'HSD3B1', 'ELK1', 'TBX19', 'POMC', 'CRHBP', 'NR4A1', 'STAR', 'CYP11A1', 'CRH', 'TLR4', 'RAPGEF3', 'MAPK3']",0.999948212053341,0,0,13
404,Cholesterol Biosynthesis Pathway WP197,0.8068812157621188,0.6584654593574631,0.14129273726976765,"['IDI1', 'HMGCS1']",0.999948212053341,0,0,2
405,Ectoderm Differentiation WP2858,0.8107864777826131,0.8313746438746439,0.1743812822967505,"['TFAP2C', 'TCF7L1', 'EDA', 'ARHGDIG', 'STC1', 'PRKAG2', 'NFATC1', 'PAX6', 'JAKMIP1', 'PTPN13', 'ZFHX4', 'VAX2', 'EDA2R', 'GLI3', 'PPFIBP2', 'MAFB', 'MYC', 'BOC', 'CCL2', 'CTNNA2', 'LY6E']",0.999948212053341,0,0,21
406,Canonical NF-KB pathway WP4562,0.8135635127951284,0.6115104640582347,0.12617373792427075,['NFKBIE'],0.999948212053341,0,0,1
407,Disorders of Folate Metabolism and Transport WP4259,0.8135635127951284,0.6115104640582347,0.12617373792427075,['ALDH1L1'],0.999948212053341,0,0,1
408,Liver X receptor pathway WP2874,0.8135635127951284,0.6115104640582347,0.12617373792427075,['CYP3A4'],0.999948212053341,0,0,1
409,Methylation Pathways WP704,0.8135635127951284,0.6115104640582347,0.12617373792427075,['MAT2B'],0.999948212053341,0,0,1
410,Mitochondrial CII Assembly WP4920,0.8135635127951284,0.6115104640582347,0.12617373792427075,['SDHAF1'],0.999948212053341,0,0,1
411,Eicosanoid Synthesis WP167,0.8151691405432282,0.6757069538089967,0.13808723851866486,"['PTGES2', 'TBXAS1', 'GGT2']",0.999948212053341,0,0,3
412,Fatty Acid Biosynthesis WP357,0.8151691405432282,0.6757069538089967,0.13808723851866486,"['ACLY', 'ECHDC3', 'ACACB']",0.999948212053341,0,0,3
413,Hippo-Yap signaling pathway WP4537,0.8151691405432282,0.6757069538089967,0.13808723851866486,"['LATS2', 'TEAD2', 'TEAD3']",0.999948212053341,0,0,3
414,Gastrin signaling pathway WP4659,0.8232427682407439,0.8076753449992886,0.1570962001282175,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'CDKN1B', 'SERPINB2', 'BAD', 'KLF4', 'ELK1', 'FOXO1', 'KAT5', 'MYC', 'PRKD2', 'PRKD1', 'HRAS', 'CD44', 'MAPK3']",0.999948212053341,0,0,17
415,PDGFR-beta pathway WP3972,0.8265182163220778,0.6846286260758687,0.13044456622075373,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,4
416,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8265182163220778,0.6846286260758687,0.13044456622075373,"['CDKN1B', 'BAD', 'HRAS', 'FOXO1']",0.999948212053341,0,0,4
417,G Protein Signaling Pathways WP35,0.8298432979299809,0.7877400568899062,0.14692801005695724,"['PRKCH', 'ADCY4', 'AKAP5', 'GNG12', 'GNG11', 'GNA14', 'GNG10', 'GNG3', 'ADCY9', 'PRKAR1A', 'PRKD1', 'CALM1', 'HRAS', 'CALM2']",0.999948212053341,0,0,14
418,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8353503932001367,0.6113867018613753,0.10999091906715962,"['MKNK2', 'MAPK3']",0.999948212053341,0,0,2
419,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8353503932001367,0.6113867018613753,0.10999091906715962,"['RAB27A', 'SYTL4']",0.999948212053341,0,0,2
420,Dopaminergic Neurogenesis WP2855,0.8353503932001367,0.6113867018613753,0.10999091906715962,"['SLC18A2', 'GLI2']",0.999948212053341,0,0,2
421,NOTCH1 regulation of endothelial cell calcification WP3413,0.8353503932001367,0.6113867018613753,0.10999091906715962,"['ALPL', 'DLL3']",0.999948212053341,0,0,2
422,Nuclear receptors WP170,0.8382556451220842,0.6900613067807768,0.12174900636676819,"['NR4A1', 'NR1I3', 'RORA', 'PGR', 'PPARA']",0.999948212053341,0,0,5
423,Trans-sulfuration and one-carbon metabolism WP2525,0.8387291993560069,0.6418738049713193,0.11288467116151933,"['AHCY', 'DNMT3A', 'MAT2B']",0.999948212053341,0,0,3
424,IL-1 signaling pathway WP195,0.8429247701237093,0.7280629673143136,0.12440962747446199,"['JUN', 'IL1R1', 'IL1B', 'TOLLIP', 'PELI2', 'CCL2', 'IRAK3', 'MAPK3']",0.999948212053341,0,0,8
425,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8465442774618008,0.6582477133959442,0.10965931141212391,"['HPGD', 'CYP4A11', 'TBXAS1', 'PTGDR']",0.999948212053341,0,0,4
426,Aspirin and miRNAs WP4707,0.8488805919865073,0.535031847133758,0.08765787793406904,['PPARA'],0.999948212053341,0,0,1
427,ATR Signaling WP3875,0.8488805919865073,0.535031847133758,0.08765787793406904,['RAD9A'],0.999948212053341,0,0,1
428,Biotin Metabolism (including IEMs) WP5031,0.8488805919865073,0.535031847133758,0.08765787793406904,['ACACB'],0.999948212053341,0,0,1
429,"Degradation pathway of sphingolipids, including diseases WP4153",0.8488805919865073,0.535031847133758,0.08765787793406904,['NEU1'],0.999948212053341,0,0,1
430,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.8488805919865073,0.535031847133758,0.08765787793406904,['TIFA'],0.999948212053341,0,0,1
431,NLR Proteins WP288,0.8488805919865073,0.535031847133758,0.08765787793406904,['ERBIN'],0.999948212053341,0,0,1
432,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8488805919865073,0.535031847133758,0.08765787793406904,['THBD'],0.999948212053341,0,0,1
433,Urea cycle and related diseases WP4571,0.8488805919865073,0.535031847133758,0.08765787793406904,['SLC25A15'],0.999948212053341,0,0,1
434,Vitamin D Metabolism WP1531,0.8488805919865073,0.535031847133758,0.08765787793406904,['GC'],0.999948212053341,0,0,1
435,ATM Signaling Network in Development and Disease  WP3878,0.8495734077805255,0.6937023147549464,0.11308799557719612,"['DCLRE1C', 'KAT5', 'CDK5', 'CDK1', 'HSPB1', 'CDK5R1']",0.999948212053341,0,0,6
436,Amino Acid metabolism WP3925,0.8525808520851914,0.7546105690598387,0.12035075177713936,"['AOC3', 'ACLY', 'TPH1', 'TPO', 'LDHA', 'PKM', 'GOT1', 'MDH2', 'ODC1', 'PDK4', 'ACSS1', 'HIBCH']",0.999948212053341,0,0,12
437,Bladder cancer WP2828,0.855602614926311,0.6684470663265306,0.10424381567032857,"['CDKN1A', 'RPS6KA5', 'MYC', 'MMP2', 'HRAS']",0.999948212053341,0,0,5
438,G13 Signaling Pathway WP524,0.855602614926311,0.6684470663265306,0.10424381567032857,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.999948212053341,0,0,5
439,Gastric Cancer Network 1 WP2361,0.8596451896308979,0.6112628607848493,0.09244467192677884,"['MCM4', 'GATD3B', 'GATD3A']",0.999948212053341,0,0,3
440,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8596451896308979,0.6112628607848493,0.09244467192677884,"['TNFRSF10B', 'PMAIP1', 'BAX']",0.999948212053341,0,0,3
441,MTHFR deficiency WP4288,0.8596451896308979,0.6112628607848493,0.09244467192677884,"['DNMT3A', 'EHMT1', 'CYCS']",0.999948212053341,0,0,3
442,Urea cycle and associated pathways WP4595,0.8596451896308979,0.6112628607848493,0.09244467192677884,"['SLC25A15', 'GOT1', 'MDH2']",0.999948212053341,0,0,3
443,Canonical and non-canonical TGF-B signaling WP3874,0.8599658373820194,0.5705851120314325,0.0860799617946948,"['LOXL1', 'TGFBR2']",0.999948212053341,0,0,2
444,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8599658373820194,0.5705851120314325,0.0860799617946948,"['JUN', 'MAPK3']",0.999948212053341,0,0,2
445,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8599658373820194,0.5705851120314325,0.0860799617946948,"['VIM', 'MAPK3']",0.999948212053341,0,0,2
446,Regulation of Actin Cytoskeleton WP51,0.8621327150177103,0.7968112335005244,0.11820380580402563,"['PDGFRA', 'CHRM1', 'MSN', 'BRK1', 'GNG12', 'F2', 'FGF2', 'ACTG1', 'PIK3R5', 'FGF17', 'VIL1', 'DIAPH3', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'PIP4K2C', 'FGFR4', 'DOCK1', 'WASF2', 'FGF10', 'MAPK3']",0.999948212053341,0,0,22
447,Notch Signaling WP268,0.8648049094969859,0.6753966255351297,0.09810226194679739,"['NOTCH3', 'KAT2B', 'DTX3L', 'MFNG', 'HES5', 'DLL3']",0.999948212053341,0,0,6
448,Regulation of Microtubule Cytoskeleton WP2038,0.8648049094969859,0.6753966255351297,0.09810226194679739,"['PARD6A', 'CFL2', 'STMN1', 'RHO', 'CDK1', 'PHLDB2']",0.999948212053341,0,0,6
449,16p11.2 proximal deletion syndrome WP4949,0.8657705537132666,0.7247914512610364,0.10446807316313017,"['SPN', 'PARP4', 'MSN', 'GDPD3', 'TBX6', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'MAPK3']",0.999948212053341,0,0,10
450,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8657705537132666,0.7247914512610364,0.10446807316313017,"['PDGFRA', 'SOCS3', 'DUSP2', 'PTPRC', 'STMN1', 'IL21R', 'CSF2RB', 'OSMR', 'MAPK15', 'MAPK3']",0.999948212053341,0,0,10
451,MET in type 1 papillary renal cell carcinoma WP4205,0.8701053069265983,0.6982418885204896,0.0971540971039245,"['CDKN1A', 'JUN', 'BAD', 'HGF', 'RPL11', 'GAB1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,8
452,Ebola Virus Pathway on Host WP4217,0.8751390553443985,0.7693371757925072,0.10260841082864594,"['VPS18', 'HLA-DRB5', 'CAV3', 'CD300A', 'CAV2', 'ICAM2', 'MERTK', 'ACTG1', 'HLA-E', 'RELB', 'BST2', 'SOCS3', 'SCIN', 'NEDD4', 'CLTCL1', 'IRF7', 'TLR4', 'MAPK3']",0.999948212053341,0,0,18
453,Dopamine metabolism WP2436,0.877509136280986,0.4755484784147205,0.062138926719762476,['TYR'],0.999948212053341,0,0,1
454,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.877509136280986,0.4755484784147205,0.062138926719762476,['MAFK'],0.999948212053341,0,0,1
455,Gene regulatory network modelling somitogenesis  WP2854,0.877509136280986,0.4755484784147205,0.062138926719762476,['TBX6'],0.999948212053341,0,0,1
456,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.877509136280986,0.4755484784147205,0.062138926719762476,['HMOX1'],0.999948212053341,0,0,1
457,Non-homologous end joining WP438,0.877509136280986,0.4755484784147205,0.062138926719762476,['DCLRE1C'],0.999948212053341,0,0,1
458,TCA cycle in senescence WP5050,0.877509136280986,0.4755484784147205,0.062138926719762476,['GOT1'],0.999948212053341,0,0,1
459,Valproic acid pathway WP3871,0.877509136280986,0.4755484784147205,0.062138926719762476,['CYP2A6'],0.999948212053341,0,0,1
460,EPO Receptor Signaling WP581,0.8781401909457123,0.5834347297062402,0.07581677562539431,"['PTPRC', 'CISH', 'MAPK3']",0.999948212053341,0,0,3
461,Glycosylation and related congenital defects WP4521,0.8781401909457123,0.5834347297062402,0.07581677562539431,"['DPM3', 'DOLK', 'MGAT2']",0.999948212053341,0,0,3
462,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8781401909457123,0.5834347297062402,0.07581677562539431,"['MYC', 'LEF1', 'DKK1']",0.999948212053341,0,0,3
463,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8807652444953525,0.611138940753222,0.07759273820539558,"['SUPT4H1', 'NFATC2', 'NFATC1', 'NFATC4']",0.999948212053341,0,0,4
464,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8811657710032664,0.5348837209302325,0.0676678766004928,"['MDH2', 'IDH3B']",0.999948212053341,0,0,2
465,PDGF Pathway WP2526,0.8856481215916857,0.6290328631452581,0.07638695876394372,"['JUN', 'ARFIP2', 'ELK1', 'HRAS', 'MAPK3']",0.999948212053341,0,0,5
466,RANKL/RANK signaling pathway WP2018,0.8861312623343175,0.6652556193717649,0.08042287671532448,"['LYN', 'JUN', 'VCAM1', 'SYK', 'NFATC1', 'RELB', 'MAPK3']",0.999948212053341,0,0,7
467,Histone Modifications WP2369,0.8914329526312951,0.641531100478469,0.07372799500211082,"['SET', 'H3F3B', 'SUV39H1', 'EHMT1', 'SMYD1', 'HIST1H3E']",0.999948212053341,0,0,6
468,Wnt signaling pathway and pluripotency WP399,0.8921904661056781,0.7297729453149984,0.08324931737617736,"['WNT10A', 'JUN', 'TCF7L1', 'PRKCH', 'FZD2', 'LEF1', 'PPM1J', 'WNT16', 'NKD1', 'FRAT1', 'CCND3', 'MYC', 'PRKD1', 'CD44']",0.999948212053341,0,0,14
469,Proteasome Degradation WP183,0.8933125680415012,0.6707597178673576,0.07567426563916535,"['PSMD8', 'PSMB6', 'PSMD7', 'H2AFZ', 'PSMD2', 'NEDD4', 'PSMB10', 'HLA-E']",0.999948212053341,0,0,8
470,Disruption of postsynaptic signaling by CNV WP4875,0.8952409314920012,0.5900212150857946,0.06529316355688641,"['ARC', 'YWHAG', 'MAPK3', 'SHANK1']",0.999948212053341,0,0,4
471,The influence of laminopathies on Wnt signaling WP4844,0.8952409314920012,0.5900212150857946,0.06529316355688641,"['CEBPB', 'TCF7L1', 'LEF1', 'HES5']",0.999948212053341,0,0,4
472,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8975009502296134,0.650744984878333,0.07037227839872179,"['KAT2B', 'CDKN1A', 'CEBPB', 'TCF7L1', 'MSTN', 'LEF1', 'HES5']",0.999948212053341,0,0,7
473,Common Pathways Underlying Drug Addiction WP2636,0.8985457988836992,0.6110149416909622,0.06536491291507605,"['DRD2', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.999948212053341,0,0,5
474,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8993606768283251,0.5033824934879974,0.053394348477902365,"['LDHA', 'ACACB']",0.999948212053341,0,0,2
475,Osteoblast Signaling WP322,0.9007155262030244,0.42796178343949043,0.04475016728684797,['PDGFRA'],0.999948212053341,0,0,1
476,Ras signaling WP4223,0.9087492689846055,0.7711432138398431,0.07378765162790359,"['CSF1R', 'FLT1', 'RASAL3', 'ELK1', 'ETS2', 'GNG10', 'GNG3', 'RAC3', 'HRAS', 'MAPK3', 'NTRK1', 'PDGFRA', 'NGFR', 'PLA2G12B', 'BAD', 'GAB1', 'GNG12', 'GNG11', 'RASA4', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'PLA1A', 'EPHA2', 'ARF6']",0.999948212053341,0,0,26
477,MECP2 and Associated Rett Syndrome WP3584,0.9094207920272565,0.6633967499009116,0.062987779586054,"['GABRR2', 'ARHGEF26', 'BCL6', 'BDNF', 'SST', 'GAD1', 'FGF2', 'MYT1', 'FKBP5']",0.999948212053341,0,0,9
478,IL-6 signaling pathway WP364,0.9101608996573389,0.5939980158730159,0.055915339306993744,"['SOCS3', 'BAD', 'GAB1', 'VIP', 'MAPK3']",0.999948212053341,0,0,5
479,MAPK Signaling Pathway WP382,0.9124660898182897,0.7976836665625325,0.07307129861422616,"['HSPB1', 'ELK1', 'FGF2', 'RELB', 'RPS6KA5', 'MYC', 'STMN1', 'MKNK2', 'RAC3', 'CACNG1', 'HRAS', 'CACNG4', 'CACNG5', 'MAPK3', 'DUSP4', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'IL1R1', 'GADD45A', 'BDNF', 'IL1R2', 'NFATC1', 'GNG12', 'DUSP6', 'TGFBR2', 'FGF17', 'NR4A1', 'DDIT3', 'IL1B', 'PTPN7', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10']",0.999948212053341,0,0,37
480,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.9149280910545907,0.4753814024282326,0.04226606817380653,"['B3GALNT1', 'B3GALT1']",0.999948212053341,0,0,2
481,Triacylglyceride synthesis WP325,0.9149280910545907,0.4753814024282326,0.04226606817380653,"['LPL', 'AGPAT1']",0.999948212053341,0,0,2
482,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9173665288308694,0.6235375452031483,0.053778979869256685,"['YAP1', 'DCLRE1C', 'RAD51', 'KAT5', 'CDK5', 'BAX', 'RAD9A']",0.999948212053341,0,0,7
483,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9196199410968219,0.551873065493023,0.0462440941389414,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9']",0.999948212053341,0,0,4
484,16p11.2 distal deletion syndrome WP4950,0.921268137909023,0.5133078393881453,0.042093371673689206,"['PLN', 'SLN', 'NFATC2']",0.999948212053341,0,0,3
485,Autophagy WP4923,0.921268137909023,0.5133078393881453,0.042093371673689206,"['ATG101', 'ATG9A', 'PRKAG2']",0.999948212053341,0,0,3
486,Oxidative Stress WP408,0.921268137909023,0.5133078393881453,0.042093371673689206,"['GPX3', 'HMOX1', 'XDH']",0.999948212053341,0,0,3
487,Kallmann's Syndrome WP5074,0.9282103604556683,0.4503277946379169,0.033548020342664193,"['PROKR2', 'CHD7']",0.999948212053341,0,0,2
488,AGE/RAGE pathway WP2324,0.9293915851668898,0.621791486521777,0.04553075399027717,"['LGALS3', 'JUN', 'MMP2', 'MSN', 'ALPL', 'CYCS', 'FOXO1', 'MAPK3']",0.999948212053341,0,0,8
489,Pathways affected in adenoid cystic carcinoma WP3651,0.9293915851668898,0.621791486521777,0.04553075399027717,"['MYCBP', 'UHRF1', 'MYC', 'INSRR', 'ERBIN', 'IL17RD', 'FGFR4', 'HRAS']",0.999948212053341,0,0,8
490,Osteopontin Signaling WP1434,0.9347741802524834,0.3565817409766454,0.024051544444287982,['MAPK3'],0.999948212053341,0,0,1
491,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9365049502531546,0.6378678310777636,0.041844430284339006,"['EDN1', 'FZD2', 'CISH', 'NPPA', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'MAPK3', 'NFATC4']",0.999948212053341,0,0,10
492,T-cell receptor (TCR) signaling pathway WP69,0.9365049502531546,0.6378678310777636,0.041844430284339006,"['JUN', 'FYB1', 'IL1B', 'NFATC2', 'NFATC1', 'CD247', 'VIM', 'HRAS', 'CARD11', 'MAPK3']",0.999948212053341,0,0,10
493,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.93655277851598,0.6106424695636314,0.04002724840301642,"['ACLY', 'IDI1', 'GSK3A', 'RBP4', 'HMGCS1', 'PRKAG2', 'LPL', 'ACSS1']",0.999948212053341,0,0,8
494,One-carbon metabolism and related pathways WP3940,0.9382873932609276,0.5481832155939299,0.03491871579760096,"['DMGDH', 'GPX4', 'GPX3', 'GAD1', 'DNMT3A']",0.999948212053341,0,0,5
495,Phosphoinositides metabolism WP4971,0.9387828685744665,0.5183489340327083,0.03274465336895764,"['PIP4P1', 'PLCZ1', 'INPP5D', 'PIP4K2C']",0.999948212053341,0,0,4
496,Non-small cell lung cancer WP4255,0.9395036584854557,0.6204115684093437,0.038715894293048295,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'MAPK3']",0.999948212053341,0,0,9
497,1q21.1 copy number variation syndrome WP4905,0.9395144299882348,0.4277795476266327,0.026690064752145005,"['PRKAG2', 'TJP2']",0.999948212053341,0,0,2
498,NAD+ biosynthetic pathways WP3645,0.9395144299882348,0.4277795476266327,0.026690064752145005,"['PARP4', 'ACMSD']",0.999948212053341,0,0,2
499,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9395144299882348,0.4277795476266327,0.026690064752145005,"['GNA14', 'RYR3']",0.999948212053341,0,0,2
500,Chemokine signaling pathway WP3929,0.9402356718507124,0.7055872768292343,0.04348161865731971,"['LYN', 'CX3CR1', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'CXCL13', 'GNG12', 'GNG11', 'CXCL5', 'PIK3R5', 'FGR', 'GNG10', 'GNG3', 'ADCY9', 'PARD3', 'CCL3', 'HRAS', 'MAPK3']",0.999948212053341,0,0,19
501,IL-9 signaling pathway WP22,0.947133525130954,0.32912787849093583,0.017876645791777505,['MAPK3'],0.999948212053341,0,0,1
502,Riboflavin and CoQ disorders WP5037,0.947133525130954,0.32912787849093583,0.017876645791777505,['RFK'],0.999948212053341,0,0,1
503,Small Ligand GPCRs WP247,0.947133525130954,0.32912787849093583,0.017876645791777505,['PTGDR'],0.999948212053341,0,0,1
504,Estrogen signaling pathway WP712,0.9491129720980258,0.4073787527116613,0.02127635105540387,"['JUN', 'ELK1']",0.999948212053341,0,0,2
505,ESC Pluripotency Pathways WP3931,0.9498014823835178,0.6571548055398391,0.03384497220197739,"['PDGFRA', 'WNT10A', 'JUN', 'FZD2', 'GAB1', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'FGF17', 'BMPR1B', 'FGFR4', 'HRAS', 'FGF10']",0.999948212053341,0,0,14
506,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9522090890621483,0.6942219374132222,0.033996490451740295,"['NSF', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'BDNF', 'BAD', 'ELK1', 'ACACB', 'NFATC4', 'RPS6KA5', 'CDK5', 'CFL1', 'IGF2BP1', 'ALPL', 'HRAS', 'MAPK3', 'CDK5R1']",0.999948212053341,0,0,20
507,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9558462279260953,0.6885716943494125,0.031094677786802763,"['NOTCH3', 'WNT10A', 'FZD2', 'MMP2', 'EIF5A2', 'TWIST2', 'WNT8A', 'CLDN2', 'FOXM1', 'WNT16', 'TGFBR2', 'DLL3', 'CLDN5', 'CLDN20', 'LATS2', 'CLDN9', 'COL4A6', 'STRAP', 'HRAS', 'MAPK3']",0.999948212053341,0,0,20
508,Prolactin Signaling Pathway WP2037,0.9559369986919275,0.5916445623342175,0.026661438095717485,"['SOCS3', 'JUN', 'CISH', 'MYC', 'ELK1', 'HRAS', 'PRLR', 'YWHAG', 'MAPK3']",0.999948212053341,0,0,9
509,Ciliary landscape WP4352,0.9562175447133954,0.7347409789210432,0.03289423209012291,"['YAP1', 'DOCK5', 'SSNA1', 'COPS7A', 'MYL6B', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'CDH23', 'NEFL', 'BBS9', 'STOM', 'NEFM', 'DCAF11', 'TFAP2C', 'NDUFA5', 'IFT140', 'WHRN', 'DYNLT3', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'MKLN1', 'MCM4', 'EFHC2', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.999948212053341,0,0,31
510,Biomarkers for pyrimidine metabolism disorders WP4584,0.9571514787369162,0.3055959963603276,0.013383153429513453,['NT5C'],0.999948212053341,0,0,1
511,Cell Differentiation - Index expanded WP2023,0.9571514787369162,0.3055959963603276,0.013383153429513453,['KLF4'],0.999948212053341,0,0,1
512,GPR40 Pathway WP3958,0.9571514787369162,0.3055959963603276,0.013383153429513453,['PLCZ1'],0.999948212053341,0,0,1
513,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9571514787369162,0.3055959963603276,0.013383153429513453,['FRAT1'],0.999948212053341,0,0,1
514,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9571514787369162,0.3055959963603276,0.013383153429513453,['ACLY'],0.999948212053341,0,0,1
515,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9619063658715388,0.5933496575463998,0.023044612393442174,"['PDGFRA', 'BAD', 'MYC', 'HGF', 'PDGFC', 'GAB1', 'BAX', 'FGF2', 'HRAS', 'MAPK3']",0.999948212053341,0,0,10
516,AMP-activated protein kinase (AMPK) signaling WP1403,0.9629578233548164,0.543893949063062,0.02052963895049696,"['GYS2', 'GYS1', 'CDKN1A', 'LEP', 'LEPR', 'PRKAG2', 'ACACB']",0.999948212053341,0,0,7
517,p53 transcriptional gene network WP4963,0.9629578233548164,0.543893949063062,0.02052963895049696,"['CDKN1A', 'GADD45A', 'CCL2', 'PMAIP1', 'BAX', 'SLC7A11', 'TNFRSF10D']",0.999948212053341,0,0,7
518,Thermogenesis WP4321,0.9633744172286446,0.6238218052242881,0.023276750235460646,"['UCP1', 'ADCY4', 'PRKAG2', 'ACTG1', 'ADCY10', 'CREB3', 'ADCY9', 'CREB3L1', 'PRDM16', 'ZNF516', 'DPF3', 'HRAS', 'PRKG1']",0.999948212053341,0,0,13
519,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.963437427851595,0.49704111295681064,0.01851365605124382,"['ARC', 'BDNF', 'PRKAG2', 'HRAS', 'MAPK3']",0.999948212053341,0,0,5
520,Integrin-mediated Cell Adhesion WP185,0.9650997115226244,0.6101447290325526,0.02167469286998872,"['CAPNS1', 'CAV3', 'CAV2', 'ITGB4', 'ITGA10', 'ITGA8', 'RHO', 'RAC3', 'ITGB8', 'HRAS', 'DOCK1', 'TNS1']",0.999948212053341,0,0,12
521,Glycosaminoglycan degradation WP4815,0.9652714847972854,0.28520169851380045,0.010080706669415745,['HPSE2'],0.999948212053341,0,0,1
522,Mammalian disorder of sexual development WP4842,0.9652714847972854,0.28520169851380045,0.010080706669415745,['FST'],0.999948212053341,0,0,1
523,NAD+ metabolism WP3644,0.9652714847972854,0.28520169851380045,0.010080706669415745,['NRK'],0.999948212053341,0,0,1
524,Integrated breast cancer pathway WP1984,0.9680973785057879,0.6668535725728933,0.021621126065417655,"['PLK3', 'JUN', 'GSK3A', 'GADD45A', 'BAD', 'ODC1', 'PHB', 'SMAD6', 'JAKMIP1', 'TFPI', 'MYT1', 'FOXO1', 'TGFBR2', 'RAD51', 'MYC', 'CDK2', 'RHO', 'BAX', 'FADD', 'FAU']",0.999948212053341,0,0,20
525,Target Of Rapamycin (TOR) Signaling WP1471,0.9686740483280999,0.4137728982914945,0.013169192699697324,"['IDI1', 'RRAGA', 'PRKAG2']",0.999948212053341,0,0,3
526,Wnt signaling in kidney disease WP4150,0.9686740483280999,0.4137728982914945,0.013169192699697324,"['WNT10A', 'FZD2', 'WNT16']",0.999948212053341,0,0,3
527,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9698833441810315,0.4499773501333825,0.013760072680431733,"['MAP1LC3A', 'ATG101', 'CP', 'FTL']",0.999948212053341,0,0,4
528,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9699325706706177,0.35637676542423274,0.010879728151680097,"['CDKN1A', 'MAPK3']",0.999948212053341,0,0,2
529,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9718530238138805,0.2673566878980892,0.007633219525925725,['ACSF2'],0.999948212053341,0,0,1
530,Pyrimidine metabolism and related diseases WP4225,0.9718530238138805,0.2673566878980892,0.007633219525925725,['NT5C'],0.999948212053341,0,0,1
531,Wnt Signaling Pathway WP363,0.9721021026313071,0.4748795351473923,0.013436448699964042,"['GSK3A', 'FRAT1', 'MYC', 'LEF1', 'NFATC2']",0.999948212053341,0,0,5
532,Pancreatic adenocarcinoma pathway WP4263,0.9723605487866781,0.5694879165335889,0.01596195376423231,"['CDKN1A', 'RAD51', 'GADD45B', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'DUSP6', 'TGFBR2', 'MAPK3']",0.999948212053341,0,0,10
533,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9771875066234189,0.251611090295991,0.005806359824972286,['MAP1LC3A'],0.999948212053341,0,0,1
534,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9775496224043418,0.427414727446605,0.009704974458132051,"['ABCA1', 'IDI1', 'HMGCS1', 'DHCR24']",0.999948212053341,0,0,4
535,Kit receptor signaling pathway WP304,0.977768049501503,0.483704974271012,0.010875044747092175,"['LYN', 'BAD', 'INPP5D', 'HRAS', 'MAPK3', 'TBX2']",0.999948212053341,0,0,6
536,Joubert Syndrome WP4656,0.9797583567341164,0.5177339949124181,0.010587304245129004,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'PDE6A', 'ARR3', 'ZNF423']",0.999948212053341,0,0,8
537,ErbB signaling pathway WP673,0.9801440368625033,0.5474616940602249,0.010979750341597077,"['CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'MYC', 'GAB1', 'ELK1', 'HRAS', 'FOXO1', 'MAPK3']",0.999948212053341,0,0,10
538,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9806537828169086,0.4169588779088301,0.008145627091394665,"['EIF4A2', 'RPS6KA5', 'PIM2', 'MAPK3']",0.999948212053341,0,0,4
539,Ebstein-Barr virus LMP1 signaling WP262,0.9815111601439505,0.23761500353857043,0.004434346206565487,['HSP90AA1'],0.999948212053341,0,0,1
540,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9815111601439505,0.23761500353857043,0.004434346206565487,['DNMT3A'],0.999948212053341,0,0,1
541,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9815880377728441,0.4450999149659864,0.008271546369340814,"['TKFC', 'CASP10', 'IRF7', 'PIN1', 'FADD']",0.999948212053341,0,0,5
542,Glioblastoma signaling pathways WP2261,0.9820616564646099,0.526491891040781,0.00953012763396899,"['PDGFRA', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDK2', 'GAB1', 'HRAS', 'FOXO1', 'MAPK3']",0.999948212053341,0,0,9
543,TGF-beta Signaling Pathway WP366,0.9821805645864391,0.6042053097345133,0.010863679868817729,"['KLF10', 'YAP1', 'JUN', 'CDKN1A', 'CITED1', 'ITGB4', 'TGFB1I1', 'TGFBR2', 'TGFBR3', 'COL1A2', 'PARD6A', 'SUMO1', 'MYC', 'CDK1', 'STRAP', 'SKP1']",0.999948212053341,0,0,16
544,SARS-CoV-2 mitochondrial interactions WP5038,0.982410282465375,0.31670855308956614,0.005620390732758609,"['IRF7', 'PHB']",0.999948212053341,0,0,2
545,Sphingolipid pathway WP1422,0.982410282465375,0.31670855308956614,0.005620390732758609,"['CERS4', 'SERINC1']",0.999948212053341,0,0,2
546,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9833490248954339,0.40700092596809206,0.006834018043708059,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.999948212053341,0,0,4
547,Energy Metabolism WP1541,0.9833490248954339,0.40700092596809206,0.006834018043708059,"['UCP3', 'PRKAG2', 'PPARA', 'FOXO1']",0.999948212053341,0,0,4
548,Vitamin D in inflammatory diseases WP4482,0.9850154753669175,0.22509218907140463,0.0033984254166000093,['NFATC1'],0.999948212053341,0,0,1
549,Type II interferon signaling (IFNG) WP619,0.985316822896708,0.30537477813680425,0.004517116518496571,"['SOCS3', 'IL1B']",0.999948212053341,0,0,2
550,Glycerolipids and Glycerophospholipids WP4722,0.9878556765053067,0.2138216560509554,0.0026126158940858986,['CDIPT'],0.999948212053341,0,0,1
551,Fatty acid beta-oxidation WP143,0.9897942552702268,0.28497398322183287,0.0029233145323456626,"['TPI1', 'LPL']",0.999948212053341,0,0,2
552,Immune response to tuberculosis WP4197,0.9901575880815936,0.20362450712769184,0.0020140843394154087,['IFIT3'],0.999948212053341,0,0,1
553,Nanoparticle triggered autophagic cell death WP2509,0.9901575880815936,0.20362450712769184,0.0020140843394154087,['MAP1LC3A'],0.999948212053341,0,0,1
554,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9915013642757301,0.27576072100216836,0.0023536053587903793,"['JUN', 'OAS2']",0.999948212053341,0,0,2
555,Sphingolipid Metabolism (general overview) WP4725,0.9920232020441226,0.19435437174290676,0.001556541952124648,['CERS4'],0.999948212053341,0,0,1
556,Ciliopathies WP4803,0.992288345902109,0.604920932060524,0.004683021202493856,"['EVC2', 'DNAH11', 'RSPH4A', 'IFT140', 'DNAH6', 'CFAP410', 'CCDC28B', 'GLI3', 'GLI2', 'RP1L1', 'TMEM17', 'SMO', 'ZIC2', 'MAK', 'SUFU', 'HYDIN', 'BBS9', 'NEK2', 'CCDC65', 'CCNQ', 'ZNF423', 'CCNO']",0.999948212053341,0,0,22
557,Interleukin-11 Signaling Pathway WP2332,0.9928004288032521,0.3204588910133843,0.002315511986172167,"['SOCS3', 'HRAS', 'MAPK3']",0.999948212053341,0,0,3
558,Sphingolipid Metabolism (integrated pathway) WP4726,0.9935351902690772,0.18589033508723346,0.001205646999054989,['CERS4'],0.999948212053341,0,0,1
559,DNA Repair Pathways Full Network WP4946,0.9937562006989631,0.5231083819910245,0.0032764230915967364,"['FEN1', 'DCLRE1C', 'CENPX', 'CETN2', 'POLE4', 'POLD4', 'NEIL2', 'RAD51', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.999948212053341,0,0,13
560,Signal Transduction of S1P Receptor WP26,0.994760563814481,0.1781316348195329,0.0009357629146133241,['MAPK3'],0.999948212053341,0,0,1
561,Head and Neck Squamous Cell Carcinoma WP4674,0.9950828255494117,0.4002392344497608,0.0019729006711154125,"['CDKN1A', 'GAB1', 'FADD', 'HRAS', 'TGFBR2', 'PIK3R5']",0.999948212053341,0,0,6
562,EGF/EGFR signaling pathway WP437,0.9958738602754632,0.5518628325005701,0.0022817738585244342,"['NDUFA13', 'JUN', 'CAV2', 'GAB1', 'NEDD8', 'ELK1', 'FOXO1', 'EPN1', 'EPS8', 'PLSCR1', 'RPS6KA5', 'INPP5D', 'NEDD4', 'CFL1', 'STMN1', 'HRAS', 'AP2M1', 'ARF6']",0.999948212053341,0,0,18
563,Insulin Signaling WP481,0.9958738602754632,0.5518628325005701,0.0022817738585244342,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'GAB1', 'ELK1', 'FOXO1', 'GYS2', 'SOCS3', 'GYS1', 'RPS6KA5', 'RHOJ', 'HRAS', 'PFKM', 'ARF6', 'MAPK3']",0.999948212053341,0,0,18
564,DNA IR-damage and cellular response via ATR WP4016,0.9958879816139187,0.41494717436006523,0.0017097881645624098,"['FEN1', 'RAD51', 'BCL6', 'CDK2', 'CDK1', 'FOXM1', 'RAD9A']",0.999948212053341,0,0,7
565,Fragile X Syndrome  WP4549,0.9964904641754526,0.4873487650093595,0.0017133762892915867,"['GABRA1', 'ARC', 'DUSP3', 'PRKAR1A', 'BDNF', 'GAD1', 'CLTCL1', 'GAB1', 'AKAP5', 'GABRD', 'AP2M1', 'SHANK1']",0.999948212053341,0,0,12
566,Nanoparticle-mediated activation of receptor signaling WP2643,0.9965584398738969,0.1644047035766781,0.000566784544314177,['HRAS'],0.999948212053341,0,0,1
567,Glycerophospholipid Biosynthetic Pathway WP2533,0.9972106514566182,0.1583038452465204,0.00044218158653102827,['CDIPT'],0.999948212053341,0,0,1
568,Resistin as a regulator of inflammation WP4481,0.9972106514566182,0.1583038452465204,0.00044218158653102827,['MAPK3'],0.999948212053341,0,0,1
569,Male infertility WP4673,0.9977183580027643,0.4442137762163313,0.0010146948334410868,"['CYP26B1', 'SPATA17', 'MSH4', 'MMP2', 'PON2', 'HMGA1', 'PEX10', 'TEX15', 'ETV5', 'SOX5']",0.999948212053341,0,0,10
570,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9977391956709515,0.15263876251137398,0.0003454770503896895,['BAX'],0.999948212053341,0,0,1
571,Splicing factor NOVA regulated synaptic proteins WP4148,0.9980793617726551,0.21906372272730987,0.0004211467249309425,"['CAV2', 'NCDN']",0.999948212053341,0,0,2
572,Interferon type I signaling pathways WP585,0.9984616643619154,0.26142349865376363,0.00040246672849775174,"['SOCS3', 'RPS6KA5', 'PTPRC']",0.999948212053341,0,0,3
573,Rett syndrome causing genes WP4312,0.9994895053622285,0.18563098189675473,9.478781725781413e-05,"['CECR2', 'GABRD']",0.999948212053341,0,0,2
574,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9997917463840104,0.3735704640073515,7.780550187624186e-05,"['GYS1', 'GSK3A', 'RPS6KA5', 'TRIP10', 'LPL', 'PRKAG2', 'CYP3A4', 'HRAS', 'FOXO1', 'MAPK3']",0.999948212053341,0,0,10
575,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998746927380031,0.3106519889385237,3.8929389286307155e-05,"['EVC2', 'TMEM17', 'IFT140', 'CDK20', 'BBS9', 'TULP3', 'DYNLL1']",0.999948212053341,0,0,7
576,mRNA Processing WP411,0.999948212053341,0.327414284310836,1.6956552567611833e-05,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.999948212053341,0,0,9
